10-Q


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-Q
(Mark One)
ý
Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the quarterly period ended September 30, 2015
or
¨
Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the transition period from                      to                     
Commission File Number: 001-34146
CLEARWATER PAPER CORPORATION
(Exact name of registrant as specified in its charter)
 
 
 
 
Delaware
 
20-3594554
(State or other jurisdiction of
incorporation or organization)
 
(I.R.S. Employer
Identification No.)
 
 
601 West Riverside, Suite 1100
Spokane, Washington
 
99201
(Address of principal executive offices)
 
(Zip Code)
(509) 344-5900
(Registrant’s telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  ý    No  ¨
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (section 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes  ý     No  ¨    
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
 
ý
  
Accelerated filer
 
¨
Non-accelerated filer
 
¨  (Do not check if a smaller reporting company)
  
Smaller reporting company
 
¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  ¨    No  ý    
The number of shares of common stock of the registrant outstanding as of October 30, 2015 was 17,773,669.




CLEARWATER PAPER CORPORATION
Index to Form 10-Q
 
 
 
 
 
 
Page Number
 
 
 
PART I.
 
 
 
 
ITEM 1.
 
 
 
 
 
 
 
 
 
 
 
6 - 21
 
 
 
ITEM 2.
22 - 35
 
 
 
ITEM 3.
 
 
 
ITEM 4.
 
 
 
PART II.
 
 
 
 
ITEM 1.
 
 
 
ITEM 1A.
 
 
 
ITEM 6.
 
 
 
 




Part I
ITEM 1.
 
Consolidated Financial Statements
Clearwater Paper Corporation
Consolidated Statements of Operations
Unaudited (Dollars in thousands - except per-share amounts)
 
 
Three Months Ended
 
Nine Months Ended
 
September 30,
 
September 30,
 
2015
 
2014
 
2015
 
2014
Net sales
$
442,222

 
$
511,142

 
$
1,320,806

 
$
1,494,821

Costs and expenses:
 
 
 
 
 
 
 
Cost of sales
(373,892
)
 
(434,457
)
 
(1,148,071
)
 
(1,295,197
)
Selling, general and administrative expenses
(28,284
)
 
(31,817
)
 
(85,379
)
 
(96,896
)
Impairment of assets

 
(890
)
 

 
(5,149
)
Total operating costs and expenses
(402,176
)
 
(467,164
)
 
(1,233,450
)
 
(1,397,242
)
Income from operations
40,046

 
43,978

 
87,356

 
97,579

Interest expense, net
(7,882
)
 
(9,570
)
 
(23,438
)
 
(30,992
)
Debt retirement costs

 
(24,420
)
 

 
(24,420
)
Earnings before income taxes
32,164

 
9,988

 
63,918

 
42,167

Income tax provision
(9,100
)
 
(3,735
)
 
(19,500
)
 
(17,235
)
Net earnings
$
23,064

 
$
6,253

 
$
44,418

 
$
24,932

Net earnings per common share:
 
 
 
 
 
 
 
Basic
$
1.22

 
$
0.32

 
$
2.33

 
$
1.23

Diluted
1.21

 
0.31

 
2.30

 
1.21

The accompanying condensed notes are an integral part of these consolidated financial statements.

2



Clearwater Paper Corporation
Consolidated Statements of Comprehensive Income
Unaudited (Dollars in thousands)
 
 
Three Months Ended
 
Nine Months Ended
 
September 30,
 
September 30,
 
2015
 
2014
 
2015
 
2014
Net earnings
$
23,064

 
$
6,253

 
$
44,418

 
$
24,932

Other comprehensive income:
 
 
 
 
 
 
 
Defined benefit pension and other postretirement employee benefits:
 
 
 
 
 
 
 
Amortization of actuarial loss included in net periodic
  cost, net of tax of $1,233, $948, $3,700 and $2,847
1,922

 
1,504

 
5,764

 
4,512

Amortization of prior service credit included in net periodic
  cost, net of tax of $(206), $(191), $(617) and $(573)
(321
)
 
(303
)
 
(962
)
 
(907
)
Other comprehensive income, net of tax
1,601

 
1,201

 
4,802

 
3,605

Comprehensive income
$
24,665

 
$
7,454

 
$
49,220

 
$
28,537

The accompanying condensed notes are an integral part of these consolidated financial statements.


3



Clearwater Paper Corporation
Consolidated Balance Sheets
Unaudited (Dollars in thousands – except per-share amounts)
 
 
September 30,
2015
 
December 31,
2014
ASSETS
 
 
 
Current assets:
 
 
 
Cash
$
13,417

 
$
27,331

Restricted cash
2,270

 
1,500

Short-term investments
10,000

 
50,000

Receivables, net
153,857

 
133,914

Taxes receivable

 
1,255

Inventories
261,683

 
286,626

Deferred tax assets
20,330

 
21,760

Prepaid expenses
6,763

 
4,191

Total current assets
468,320

 
526,577

Property, plant and equipment, net
836,758

 
810,987

Goodwill
209,087

 
209,087

Intangible assets, net
21,231

 
24,956

Pension assets
8,743

 
4,738

Other assets, net
7,394

 
9,583

TOTAL ASSETS
$
1,551,533

 
$
1,585,928

LIABILITIES AND STOCKHOLDERS’ EQUITY
 
 
 
Current liabilities:
 
 
 
Accounts payable and accrued liabilities
$
244,953

 
$
215,826

Current liability for pensions and other postretirement employee benefits
7,915

 
7,915

Total current liabilities
252,868

 
223,741

Long-term debt
575,000

 
575,000

Liability for pensions and other postretirement employee benefits
113,531

 
118,464

Other long-term obligations
47,696

 
56,856

Accrued taxes
1,573

 
2,696

Deferred tax liabilities
100,884

 
111,634

Stockholders’ equity:
 
 
 
Preferred stock, par value $0.0001 per share, 5,000,000 authorized shares, no shares
  issued

 

Common stock, par value $0.0001 per share, 100,000,000 authorized
  shares-24,153,978 and 24,056,057 shares issued
2

 
2

Additional paid-in capital
341,130

 
334,074

Retained earnings
508,742

 
464,324

Treasury stock, at cost, common shares-6,249,196 and 4,498,388 shares repurchased
(323,832
)
 
(230,000
)
Accumulated other comprehensive loss, net of tax
(66,061
)
 
(70,863
)
Total stockholders’ equity
459,981

 
497,537

TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY
$
1,551,533

 
$
1,585,928

The accompanying condensed notes are an integral part of these consolidated financial statements.

4



Clearwater Paper Corporation
Consolidated Statements of Cash Flows
Unaudited (Dollars in thousands)
 
 
Nine Months Ended
 
September 30,
 
2015
 
2014
CASH FLOWS FROM OPERATING ACTIVITIES
 
 
 
Net earnings
$
44,418

 
$
24,932

Adjustments to reconcile net earnings to net cash flows from operating activities:
 
 
 
Depreciation and amortization
62,844

 
66,539

Equity-based compensation expense
2,495

 
9,201

Impairment of assets

 
5,149

Deferred tax (benefit) provision
(12,403
)
 
12,895

Employee benefit plans
2,122

 
1,603

Deferred issuance costs and discounts on long-term debt
714

 
5,864

Disposal of plant and equipment, net
1,109

 
747

Non-cash adjustments to unrecognized taxes
(1,123
)
 
149

Changes in working capital, net
15,471

 
(13,190
)
Changes in taxes receivable, net
1,255

 
7,894

Excess tax benefits from equity-based payment arrangements
(3,848
)
 
(1,508
)
Funding of qualified pension plans
(3,179
)
 
(15,957
)
Other, net
(2,320
)
 
(2,387
)
Net cash flows from operating activities
107,555

 
101,931

CASH FLOWS FROM INVESTING ACTIVITIES
 
 
 
Changes in short-term investments, net
40,000

 
70,000

Additions to plant and equipment
(78,461
)
 
(54,029
)
Proceeds from sale of assets
587

 
733

Net cash flows from investing activities
(37,874
)
 
16,704

CASH FLOWS FROM FINANCING ACTIVITIES
 
 
 
Proceeds from long-term debt

 
300,000

Repayment of long-term debt

 
(375,000
)
Purchase of treasury stock
(84,305
)
 
(100,000
)
Changes in short-term borrowings, net

 
47,047

Payments for long-term debt issuance costs

 
(2,995
)
Payment of tax withholdings on equity-based payment arrangements
(3,129
)
 
(792
)
Excess tax benefits from equity-based payment arrangements
3,848

 
1,508

Other, net
(9
)
 
1,500

Net cash flows from financing activities
(83,595
)
 
(128,732
)
Decrease in cash
(13,914
)
 
(10,097
)
Cash at beginning of period
27,331

 
23,675

Cash at end of period
$
13,417

 
$
13,578

 
 
 
 
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
 
 
 
Cash paid for interest, net of amounts capitalized
$
28,429

 
$
34,418

Cash paid for income taxes
18,886

 
6,196

Cash received from income tax refunds
2,104

 
10,496

SUPPLEMENTAL DISCLOSURES OF NON-CASH INVESTING AND FINANCING
  ACTIVITIES
 
 
 
Changes in accrued plant and equipment
$
5,165

 
$
3,831

Unsettled repurchases of common stock
9,527

 

The accompanying condensed notes are an integral part of these consolidated financial statements.

5



Clearwater Paper Corporation
Condensed Notes to Consolidated Financial Statements
Unaudited
NOTE 1 Nature of Operations and Basis of Presentation
GENERAL
Clearwater Paper manufactures quality consumer tissue, away-from-home tissue, parent roll tissue, bleached paperboard and pulp at manufacturing facilities across the nation. The company is a premier supplier of private label tissue to major retailers and wholesale distributors, including grocery, drug, mass merchants and discount stores. In addition, the company produces bleached paperboard used by quality-conscious printers and packaging converters.
On December 30, 2014, we sold our specialty business and mills to a private buyer for $108 million in cash, net of sale related expenses and adjustments. The specialty business and mills' production consisted predominantly of machine-glazed tissue and also included parent rolls and other specialty tissue products such as absorbent materials and dark-hued napkins. The sale included five of our former subsidiaries with facilities located at East Hartford, Connecticut; Menominee, Michigan; Gouverneur, New York; St. Catharines, Ontario; and Wiggins, Mississippi. Included in the sale related expenses and adjustments was the impact of certain indemnity and working capital escrow clauses in the sales agreement. These escrowed amounts totaled $3.8 million of restricted cash on our December 31, 2014 Consolidated Balance Sheet. During the second quarter of 2015, the working capital escrow account established in connection with the sale of the specialty business and mills was settled, resulting in the release of $1.5 million from the restricted cash escrow account and the recognition of a corresponding gain recorded in "Selling, general and administrative expenses" within our Consolidated Statement of Operations.
On February 17, 2014, we announced the permanent and immediate closure of our Long Island, New York, tissue converting and distribution facility. As of September 30, 2015, we have incurred $20.8 million of costs associated with the closure, of which $0.7 million and $2.0 million, respectively, were incurred during the three and nine month periods ended September 30, 2015.
FINANCIAL STATEMENT PREPARATION AND PRESENTATION
The accompanying Consolidated Balance Sheets at September 30, 2015 and December 31, 2014, the related Consolidated Statements of Operations and Comprehensive Income for the three and nine months ended September 30, 2015 and 2014, and the Consolidated Statements of Cash Flows for the nine months ended September 30, 2015 and 2014, have been prepared in conformity with accounting principles generally accepted in the United States of America, or GAAP. We believe that all adjustments necessary for a fair statement of the results of the interim periods presented have been included. The results of operations for any interim period are not necessarily indicative of the results of operations to be expected for the full year.
This Quarterly Report on Form 10-Q should be read in conjunction with our Annual Report on Form 10-K for the year ended December 31, 2014, as filed with the Securities and Exchange Commission, or SEC, on February 26, 2015.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
SIGNIFICANT ESTIMATES
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of net sales and expenses during the reporting periods. Significant areas requiring the use of estimates and measurement of uncertainty include determination of net realizable value for deferred tax assets, uncertain tax positions, assessment of impairment of long-lived assets, goodwill and intangibles, assessment of environmental matters, equity-based compensation and pension and postretirement obligation assumptions. Actual results could differ from those estimates and assumptions.
SHORT-TERM INVESTMENTS AND RESTRICTED CASH
Our short-term investments are invested primarily in demand deposits, which have very short maturity periods, and therefore earn an interest rate commensurate with low-risk instruments. We do not attempt to hedge our exposure to interest rate risk for our short-term investments. Our restricted cash in which the underlying instrument has a term of greater than twelve months from the balance sheet date is classified as non-current and is included in “Other assets, net” on our Consolidated Balance Sheet. As of September 30, 2015, we had $2.3 million classified as current on our Consolidated Balance Sheet. As of December 31, 2014, we had $1.5 million of restricted cash classified as current and $2.3 million of restricted cash classified as non-current and included in "Other assets, net" on our Consolidated Balance Sheets.

6



TRADE ACCOUNTS RECEIVABLE
Trade accounts receivable are stated at the amount we expect to collect. Trade accounts receivable do not bear interest. The allowance for doubtful accounts is our best estimate of the losses we expect will result from the inability of our customers to make required payments. We generally determine the allowance based on a combination of actual historical write-off experience and an analysis of specific customer accounts. As of September 30, 2015 and December 31, 2014, we had allowances for doubtful accounts of $1.6 million and $1.4 million, respectively.
PROPERTY, PLANT AND EQUIPMENT
Property, plant and equipment are stated at cost, including any interest costs capitalized, less accumulated depreciation. Depreciation of buildings, equipment and other depreciable assets is determined using the straight-line method. Assets we acquire through business combinations have estimated lives that are typically shorter than the assets we construct or buy new. Accumulated depreciation totaled $1,503.7 million and $1,450.1 million at September 30, 2015 and December 31, 2014, respectively.
Consistent with authoritative guidance, we assess the carrying amount of long-lived assets with definite lives that are held-for-use and evaluate them for recoverability whenever events or changes in circumstances indicate that we may be unable to recover the carrying amount of the assets. During the first quarter of 2014, we permanently closed our Long Island tissue converting and distribution facility. As a result of this closure, we considered an outside third party's appraisal in assessing the recoverability of the facility's long-lived plant and equipment based on available market data for comparable assets sold through private party transactions. Based on this assessment, we determined the carrying amounts of certain long-lived plant and equipment related to the Long Island facility exceeded their fair value. As a result, we recorded a $3.8 million non-cash impairment charge to our accompanying Consolidated Statement of Operations for the nine months ended September 30, 2014. There were no other such events or changes in circumstances that impacted our remaining long-lived assets.
STOCKHOLDERS’ EQUITY
On December 15, 2014, we announced that our Board of Directors had approved a new stock repurchase program authorizing the repurchase of up to $100 million of our common stock. The repurchase program authorized purchases of our common stock from time to time through open market purchases, negotiated transactions or other means, including accelerated stock repurchases and 10b5-1 trading plans in accordance with applicable securities laws and other restrictions. In total, we repurchased 1,750,808 shares of our outstanding common stock as of September 30, 2015, pursuant to this repurchase program, of which 1,151,313 shares were repurchased during the third quarter of 2015 at an average price of $49.23 per share. Included in our third quarter 2015 repurchases were 201,300 shares of our outstanding common stock with an average price of $47.33 per share for which payment had not been made nor had the repurchased shares settled as of the end of the quarter. As a result, our treasury stock repurchases reported in our September 30, 2015 Consolidated Statement of Cash Flows differs from our total repurchases during the year to the extent that these repurchases had not been paid and settled at the end of the quarter. As of September 30, 2015, we had up to $6.2 million of authorization remaining pursuant to this stock repurchase program. Subsequent to the close of our third quarter ended September 30, 2015, we repurchased an additional 131,113 shares of our outstanding common stock at an average price of $46.97 per share, which completed the remainder of this repurchase program.
On February 5, 2014, we announced that our Board of Directors had approved a stock repurchase program authorizing the repurchase of up to $100 million of our common stock. We completed that program during the third quarter of 2014. In total, we repurchased 1,574,748 shares of our outstanding common stock at an average price of $63.50 per share under that program.
DERIVATIVES
We had no activity during the nine months ended September 30, 2015 and 2014 that required hedge or derivative accounting treatment. However, to help mitigate our exposure to market risk for changes in utility commodity pricing, we use firm price contracts to supply a portion of the natural gas requirements for our manufacturing facilities. As of September 30, 2015, these contracts covered approximately 51% of our expected average monthly natural gas requirements for the remainder of 2015, plus lesser amounts for 2016. Historically, these contracts have qualified for treatment as “normal purchases or normal sales” under authoritative guidance and thus required no mark-to-market adjustment.
EMPLOYEES
Unions represent hourly employees at six of our manufacturing sites. There are no collective bargaining agreements due to expire in 2015. The hourly union labor contracts that had expired as set forth on page 6 of our Annual Report on Form 10-K for the year ended December 31, 2014 were ratified during the first quarter of 2015.

7



NOTE 2 Recently Adopted and New Accounting Standards
In July 2015, the Financial Accounting Standards Board, or FASB, issued Accounting Standard Update, or ASU, 2015-11, Simplifying the Measurement of Inventory. This standard is part of the FASB’s simplification initiative and applies to entities that measure inventory using a method other than last-in, first-out (LIFO) or the retail inventory method (e.g., first-in, first-out (FIFO), average cost). Under this ASU, entities that utilize FIFO and average cost must switch from the lower of cost or market to the lower of cost and net realizable value. This ASU requires prospective adoption for inventory measurements for fiscal years beginning after December 15, 2016, and interim periods within those years for public business entities. Early adoption is permitted. We are currently evaluating the impact this guidance will have on our consolidated financial statements.
In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers. The core principle of the new standard is for companies to recognize revenue in a manner that depicts the transfer of goods or services to customers in amounts that reflect the consideration, or payment, to which the company expects to be entitled in exchange for those goods or services. The standard will also result in enhanced disclosures about revenue, provide guidance for transactions that were not previously addressed comprehensively, such as service revenue and contract modifications, and clarify guidance for multiple-element arrangements. This standard was originally issued as effective for fiscal years and interim periods within those years beginning after December 15, 2016, with early adoption prohibited. However, in July 2015, the FASB approved deferring the effective date by one year to December 15, 2017 for annual reporting periods beginning after that date. In its approval, the FASB also permitted the early adoption of the standard, but not before the original effective date of fiscal years beginning after December 15, 2016. The standard may be applied under either a retrospective or cumulative effect adoption method. We plan on adopting the standard under the deferred effective date and are currently evaluating the impact this guidance will have on our consolidated financial statements.
In April 2015, the FASB issued ASU 2015-03, Simplifying the Presentation of Debt Issuance Costs. This standard amends existing guidance to require the presentation of debt issuance costs in the balance sheet as a deduction from the carrying amount of the related debt liability instead of a deferred asset. It is effective for annual reporting periods beginning after December 15, 2015, with early adoption permitted. The adoption of this guidance is not expected to have a significant effect on our consolidated financial statements.
We reviewed all other new accounting pronouncements issued in the period and concluded that they are not applicable to our business.
NOTE 3 Inventories
Inventories at the balance sheet dates consist of:

(In thousands)
September 30, 2015
 
December 31, 2014
Pulp, paperboard and tissue products
$
163,314

 
$
188,760

Materials and supplies
79,421

 
74,916

Logs, pulpwood, chips and sawdust
18,948

 
22,950

 
$
261,683

 
$
286,626


8



NOTE 4 Intangible Assets
Intangible assets at the balance sheet dates are comprised of the following:

 
September 30, 2015
(Dollars in thousands, lives in years)
Useful
Life
 
Historical
Cost
 
Accumulated
Amortization
 
Net
Balance
Customer relationships
9.0
 
$
41,001

 
$
(21,639
)
 
$
19,362

Trade names and trademarks
10.0
 
3,286

 
(1,561
)
 
1,725

Non-compete agreements
5.0
 
574

 
(430
)
 
144

 
 
 
$
44,861

 
$
(23,630
)
 
$
21,231

 
 
 
 
 
 
 
 
  
December 31, 2014
(Dollars in thousands, lives in years)
Useful
Life
 
Historical
Cost
 
Accumulated
Amortization
 
Net
Balance
Customer relationships
9.0
 
$
41,001

 
$
(18,223
)
 
$
22,778

Trade names and trademarks
10.0
 
3,286

 
(1,314
)
 
1,972

Non-compete agreements
5.0
 
1,189

 
(983
)
 
206

 
 
 
$
45,476

 
$
(20,520
)
 
$
24,956

As a result of the closure of our Long Island tissue converting and distribution facility, we performed an assessment of the recoverability of our intangible assets by utilizing the income approach, which discounts projected future cash flows based on management’s expectations of the current and future operating environment. It was determined that the carrying amounts of certain trade names and trademarks related to the Long Island facility were exceeding their fair value. As a result, in the first quarter of 2014 we recorded a $1.3 million non-cash impairment charge in our accompanying Consolidated Statement of Operations. There were no other such events or changes in circumstances that impacted our remaining definite-lived intangible assets.
NOTE 5 Income Taxes
Consistent with authoritative guidance, our estimated annual effective tax rate is used to allocate our expected annual income tax provision to interim periods. The rate is the ratio of our estimated annual income tax provision to estimated pre-tax ordinary income and excludes "discrete items," which are significant, unusual or infrequent items reported separately, net of their related tax effect. The estimated annual effective tax rate is applied to the current interim period’s ordinary income to determine the income tax provision allocated to the interim period. The income tax effects of discrete items are then determined separately and recognized in the interim period in which the income or expense items arise.
For the three and nine months ended September 30, 2015 and 2014, the effective tax rates attributable to continuing operations were as follows:
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
2015
 
2014
 
2015
 
2014
Statutory federal income tax rate
35.0
 %
 
35.0
 %
 
35.0
 %
 
35.0
 %
State taxes, net of credits
3.3

 
(0.3
)
 
3.3

 
(0.3
)
Change in valuation allowances
(6.8
)
 
2.6

 
(3.2
)
 
2.6

Federal manufacturing deduction
(3.5
)
 
(1.4
)
 
(3.5
)
 
(1.4
)
Settlement of uncertain tax positions

 
(0.8
)
 

 
(0.2
)
Change in uncertain tax positions
(0.5
)
 
1.9

 
(1.8
)
 
0.5

Interest accrued on uncertain tax positions

 
0.2

 

 
0.1

Federal credits and audit adjustments
(0.5
)
 
0.5

 
(0.5
)
 
(0.8
)
State rate adjustments
(0.2
)
 
(0.5
)
 
(0.1
)
 
2.3

Return to provision adjustments
(0.4
)
 
(0.1
)
 
(0.2
)
 
3.2

Other
1.9

 
0.3

 
1.5

 
(0.1
)
Effective tax rate
28.3
 %
 
37.4
 %
 
30.5
 %
 
40.9
 %

9



Our estimated annual effective tax rate for the third quarter of 2015 is approximately 36%, compared with approximately 35% for the comparable interim period in 2014. The increase is due to an increase in the benefit from the federal manufacturing deduction offset by a decrease in the benefit from state income tax rates.
During the three and nine month periods ended September 30, 2015, we recorded discrete benefits for the release of valuation allowances on certain state net operating losses. Based upon further review and analysis, we determined these valuation allowances were no longer required, which reduced tax expense by approximately $2 million, or a 5.6% and 2.8% rate reduction for the three and nine month periods ended September 30, 2015, respectively.
During the nine months ended September 30, 2014, we recorded discrete expense for a reduction in our blended state tax rate, as well as adjustments to New York state specific deferred items. These changes were due to amendments we made to our New York state return filings as a result of changes in New York state tax laws. In reviewing the changes in the tax laws, we identified that in prior years we had not applied the proper apportionment factor when certain New York state net operating loss carryforwards were generated, which resulted in a $2.9 million overstatement. We corrected this in the second quarter of 2014 by including the overstatement as a discrete item within state rate adjustments due to immateriality.
NOTE 6 Accounts Payable and Accrued Liabilities
Accounts payable and accrued liabilities at the balance sheet dates consist of:
(In thousands)
September 30, 2015
 
December 31, 2014
Trade accounts payable
$
143,734

 
$
122,856

Accrued wages, salaries and employee benefits
41,467

 
41,880

Income taxes payable
11,323

 

Unsettled repurchases of common stock
9,527

 

Accrued discounts and allowances
8,801

 
10,026

Accrued taxes other than income taxes payable
7,572

 
5,622

Accrued utilities
5,967

 
6,959

Accrued interest
4,931

 
12,173

Other
11,631

 
16,310

 
$
244,953

 
$
215,826

NOTE 7 Debt
SENIOR NOTES
On July 29, 2014, we issued $300 million aggregate principal amount of senior notes, which we refer to as the 2014 Notes. The 2014 Notes mature on February 1, 2025, have an interest rate of 5.375% and were issued at their face value.
The 2014 Notes are guaranteed by all of our direct and indirect subsidiaries. The 2014 Notes will also be guaranteed by each of our future direct and indirect subsidiaries that do not constitute an immaterial subsidiary under the indenture governing the 2014 Notes. The 2014 Notes are equal in right of payment with all other existing and future unsecured senior indebtedness and are senior in right of payment to any future subordinated indebtedness. The 2014 Notes are effectively subordinated to all of our existing and future secured indebtedness, including borrowings under our secured revolving credit facility, which is secured by certain of our accounts receivable, inventory and cash. The terms of the 2014 Notes limit our ability and the ability of any restricted subsidiaries to incur certain liens, engage in sale and leaseback transactions and consolidate, merge with, or convey, transfer or lease substantially all of our or their assets to another person.
On January 23, 2013, we issued $275 million aggregate principal amount of senior notes, which we refer to as the 2013 Notes. The 2013 Notes mature on February 1, 2023, have an interest rate of 4.5% and were issued at their face value.
The 2013 Notes are guaranteed by all of our direct and indirect subsidiaries, and will also be guaranteed by each of our future direct and indirect subsidiaries that we do not designate as an unrestricted subsidiary under the indenture governing these notes. The 2013 Notes are equal in right of payment with all other existing and future unsecured senior indebtedness and are senior in right of payment to any future subordinated indebtedness. In addition, they are effectively subordinated to all of our existing and future secured indebtedness, including borrowings under our secured revolving credit facility, which is secured by certain of our accounts receivable, inventory and cash. The terms of the notes limit our ability and the ability of any restricted subsidiaries to borrow money; pay dividends; redeem or repurchase capital stock; make investments; sell assets; create restrictions on the payment of dividends or other amounts to us from any restricted subsidiaries; enter into transactions with affiliates; enter into sale and lease back transactions; create liens; and consolidate, merge or sell all or substantially all of our or their assets.

10



REVOLVING CREDIT FACILITY
On November 26, 2008, we entered into a $125 million senior secured revolving credit facility with certain financial institutions. The amount available to us under the revolving credit facility is based on the lesser of 85% of our eligible accounts receivable plus approximately 65% of our eligible inventory, or $125 million. The revolving credit facility, which was subsequently amended on September 28, 2015, expires on September 30, 2020.
As of September 30, 2015, there were no borrowings outstanding under the credit facility, but $6.2 million of the credit facility was being used to support outstanding standby letters of credit. Loans under the credit facility bear interest (i) for LIBOR loans, LIBOR plus between 1.25% and 1.75% and (ii) for base rate loans, a per annum rate equal to the greater of the following rates plus between 0.25% and 0.75%: (a) the rate of interest announced by Bank of America from time to time as its prime rate for such day; (b) the weighted average of interest rates on overnight federal funds transactions with members of the Federal Reserve System arranged by federal funds brokers for such day, plus 0.50%; or (c) LIBOR for a 30-day interest period as determined on such day, plus 1.00%. The percentage margin on all loans is based on our fixed charge coverage ratio for the most recent four quarters. As of September 30, 2015, we would have been permitted to draw an additional $118.8 million under the credit facility at LIBOR plus 1.25%, or base rate plus 0.25%.
A minimum fixed charge coverage ratio is the only financial covenant requirement under our credit facility and is triggered when there are any commitments or obligations outstanding and availability falls below 12.5% or an event of default exists, at which time the minimum fixed charge coverage ratio must be at least 1.0-to-1.0. As of September 30, 2015, the fixed charge coverage ratio for the most recent four quarters was 1.6-to-1.0.
Our obligations under the revolving credit facility are secured by certain of our accounts receivable, inventory and cash. The terms of the credit facility contain various provisions that limit our discretion in the operations of our business by restricting our ability to, among other things, pay dividends; redeem or repurchase capital stock; create, incur or guarantee certain debt; incur liens on certain properties; make capital expenditures; enter into certain affiliate transactions; enter into certain hedging arrangements; and consolidate with or merge with another entity. The revolving credit facility contains usual and customary affirmative and negative covenants and usual and customary events of default.
NOTE 8 Other Long-Term Obligations
Other long-term obligations at the balance sheet dates consist of:
 
(In thousands)
September 30, 2015
 
December 31, 2014
Long-term lease obligations, net of current portion
$
24,253

 
$
24,805

Deferred proceeds
10,921

 
12,360

Deferred compensation
10,134

 
14,609

Other
2,388

 
5,082

 
$
47,696

 
$
56,856


11



NOTE 9 Accumulated Other Comprehensive Loss
Accumulated other comprehensive loss, net of tax, is comprised of the following:
(In thousands)
Foreign Currency Translation Adjustments1
 
Pension and Other Post Retirement Employee Benefit Plan Adjustments
 
Total
Balance at December 31, 2014
$

 
$
(70,863
)
 
$
(70,863
)
Other comprehensive income, net of tax2

 
4,802

 
4,802

Balance at September 30, 2015
$

 
$
(66,061
)
 
$
(66,061
)
 
 
 
 
 
 
(In thousands)
Foreign Currency Translation Adjustments1
 
Pension and Other Post Retirement Employee Benefit Plan Adjustments
 
Total
Balance at December 31, 2013
$
(874
)
 
$
(57,219
)
 
$
(58,093
)
Other comprehensive income, net of tax2

 
3,605

 
3,605

Balance at September 30, 2014
$
(874
)
 
$
(53,614
)
 
$
(54,488
)
1 
This balance consists of unrealized foreign currency translation adjustments related to the operations of our former Canadian subsidiary before its functional currency was changed from Canadian dollars to U.S. dollars in 2012. As a result of the divestiture of the specialty business and mills, this balance was written off in the fourth quarter of 2014.
2 
For the nine months ended September 30, 2015 and 2014, net periodic costs associated with our pension and other postretirement employee benefit, or OPEB, plans included in other comprehensive income and reclassified from accumulated other comprehensive loss included $9.5 million and $7.4 million, respectively, of actuarial loss amortization, as well as $1.6 million and $1.5 million, respectively, of prior service credit amortization, all net of tax totaling $3.1 million and $2.3 million, respectively. These accumulated other comprehensive loss components are included in the computation of net periodic pension and OPEB costs in Note 10, “Pension and Other Postretirement Employee Benefit Plans.”
NOTE 10 Pension and Other Postretirement Employee Benefit Plans
The following table details the components of net periodic cost of our company-sponsored pension and OPEB plans for the periods presented:
 
Three Months Ended September 30,
(In thousands)
2015
 
2014
 
2015
 
2014
 
Pension Benefit Plans
 
Other Postretirement
Employee  Benefit Plans
Service cost
$
311

 
$
347

 
$
91

 
$
114

Interest cost
3,483

 
3,707

 
970

 
1,142

Expected return on plan assets
(5,029
)
 
(5,049
)
 

 

Amortization of prior service cost (credit)
18

 
51

 
(545
)
 
(545
)
Amortization of actuarial loss (gain)
3,155

 
2,524

 

 
(72
)
Net periodic cost
$
1,938

 
$
1,580

 
$
516

 
$
639

 
Nine Months Ended September 30,
(In thousands)
2015
 
2014
 
2015
 
2014
 
Pension Benefit Plans
 
Other Postretirement
Employee  Benefit Plans
Service cost
$
934

 
$
1,042

 
$
272

 
$
340

Interest cost
10,448

 
11,119

 
2,910

 
3,424

Expected return on plan assets
(15,087
)
 
(15,147
)
 

 

Amortization of prior service cost (credit)
54

 
154

 
(1,633
)
 
(1,634
)
Amortization of actuarial loss (gain)
9,464

 
7,573

 

 
(214
)
Net periodic cost
$
5,813

 
$
4,741

 
$
1,549

 
$
1,916


12



During the nine months ended September 30, 2015, we contributed $3.2 million to our qualified pension plans. We do not expect to make additional contributions in 2015.
During the nine months ended September 30, 2015, we made contributions of $0.3 million to our company-sponsored non-qualified pension plan, and we estimate contributions will total $0.4 million in 2015. We do not anticipate funding our OPEB plans in 2015 except to pay benefit costs as incurred during the year by plan participants.
During the three and nine months ended September 30, 2015, $1.7 million and $5.1 million, respectively, of net periodic pension and OPEB costs were charged to "Cost of sales," and $0.8 million and $2.3 million, respectively, were charged to "Selling, general and administrative expenses" in the accompanying Consolidated Statements of Operations. During the three and nine months ended September 30, 2014, $1.6 million and $4.9 million, respectively, of net periodic pension and OPEB costs were charged to "Cost of sales," and $0.6 million and $1.7 million, respectively, were charged to "Selling, general and administrative expenses" in the accompanying Consolidated Statements of Operations.
NOTE 11 Earnings per Common Share
Basic earnings per share are based on the weighted average number of shares of common stock outstanding. Diluted earnings per share are based upon the weighted average number of shares of common stock outstanding plus all potentially dilutive securities that were assumed to be converted into common shares at the beginning of the period under the treasury stock method.
The following table reconciles the number of common shares used in calculating the basic and diluted net earnings per share:
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
2015
 
2014
 
2015
 
2014
Basic average common shares outstanding1
18,860,017

 
19,755,095

 
19,088,348

 
20,321,808

Incremental shares due to:
 
 
 
 
 
 
 
Restricted stock units
89,727

 
88,262

 
78,147

 
81,304

Performance shares
140,851

 
256,303

 
117,543

 
255,509

Stock options

 

 
54

 

Diluted average common shares outstanding
19,090,595

 
20,099,660

 
19,284,092

 
20,658,621

 
 
 
 
 
 
 
 
Basic net earnings per common share
$
1.22

 
$
0.32

 
$
2.33

 
$
1.23

Diluted net earnings per common share
1.21

 
0.31

 
2.30

 
1.21

 
 
 
 
 
 
 
 
Anti-dilutive shares excluded from calculation
282,769

 
181,851

 
309,018

 
231,469

1 
Basic average common shares outstanding include restricted stock awards that are fully vested, but are deferred for future issuance.


13



NOTE 12 Equity-Based Compensation
We recognize equity-based compensation expense for all equity-based payment awards made to employees and directors, including restricted stock units, or RSUs, performance shares and stock options, based on estimated fair values.
EMPLOYEE AWARDS
Employee equity-based compensation expense was recognized as follows:
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
(In thousands)
2015
 
2014
 
2015
 
2014
Restricted stock units
$
572

 
$
593

 
$
1,535

 
$
1,625

Performance shares
1,182

 
1,473

 
3,225

 
4,028

Stock options
636

 
410

 
1,577

 
953

Total employee equity-based compensation
$
2,390

 
$
2,476

 
$
6,337

 
$
6,606

As provided for in the Clearwater Paper Corporation 2008 Stock Incentive Plan, the performance measure used to determine the number of performance shares ultimately issued is a comparison of the percentile ranking of our total stockholder return compared to the total stockholder return of a selected peer group. The number of shares actually issued, as a percentage of the amount subject to the performance share award, could range from 0%-200%. On December 31, 2014, the service and performance period for 137,775 outstanding performance shares granted in 2012 ended. Those performance shares were settled and distributed in the first quarter of 2015. The number of shares actually settled, as a percentage of the outstanding amount, was 106.9%. After adjusting for the related minimum tax withholdings, a net 97,921 shares were issued in the first quarter of 2015. The related minimum tax withholdings payment made during 2015 in connection with issued shares was $3.1 million. No restricted stock units vested and settled during the first nine months of 2015.
The following table summarizes the number of share-based awards granted under the Clearwater Paper Corporation 2008 Stock Incentive Plan during the nine months ended September 30, 2015 and the grant-date fair value of the awards:
 
 
Nine Months Ended
 
September 30, 2015
 
Number of
Shares Subject to Award
 
Average Fair Value of
Award Per Share
Restricted stock units
23,148

 
$
62.02

Performance shares
47,513

 
62.05

Stock options
142,542

 
20.82

DIRECTOR AWARDS
Annually, each outside member of our Board of Directors receives deferred equity-based awards that are measured in units of our common stock and ultimately settled in cash at the time of payment. Accordingly, the compensation expense associated with these awards is subject to fluctuations each quarter based on mark-to-market adjustments at each reporting period in line with changes in the market price of our common stock. As a result of the mark-to-market adjustment, we recorded benefits from director equity-based compensation of $1.9 million and $0.2 million for the three months ended September 30, 2015 and 2014, respectively. For the nine months ended September 30, 2015, we recorded a benefit relating to our director equity-based compensation of $3.8 million, compared to compensation expense of $2.6 million for the same period in 2014.
As of September 30, 2015, the liability amount associated with director equity-based compensation included in "Other long-term obligations" on the accompanying Consolidated Balance Sheet was $9.7 million. At December 31, 2014, liability amounts associated with director equity-based compensation included in "Other long-term obligations" and "Accounts payable and accrued liabilities" totaled $13.5 million and $1.4 million, respectively.

14



NOTE 13 Fair Value Measurements
The estimated fair values of our financial instruments at the dates presented below are as follows:
 
 
September 30,
 
December 31,
 
2015
 
2014
 
Carrying
 
Fair
 
Carrying
 
Fair
(In thousands)
Amount
 
Value
 
Amount
 
Value
Cash, restricted cash and short-term investments (Level 1)
$
25,687

 
$
25,687

 
$
81,101

 
$
81,101

Long-term debt (Level 1)
575,000

 
549,500

 
575,000

 
558,000

Accounting guidance establishes a framework for measuring the fair value of financial instruments, providing a hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities, or “Level 1” measurements, followed by quoted prices of similar assets or observable market data, or “Level 2” measurements, and the lowest priority to unobservable inputs, or “Level 3” measurements.
The asset’s or liability’s fair value measurement level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Valuation techniques used should seek to maximize the use of observable inputs and minimize the use of unobservable inputs.
NOTE 14 Segment Information
The table below presents information about our reportable segments:
 
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
(In thousands)
2015
 
2014
 
2015
 
2014
Segment net sales:
 
 
 
 
 
 
 
Consumer Products
$
247,039

 
$
306,104

 
$
721,606

 
$
891,742

Pulp and Paperboard
195,183

 
205,038

 
599,200

 
603,079

Total segment net sales
$
442,222

 
$
511,142

 
$
1,320,806

 
$
1,494,821

 
 
 
 
 
 
 
 
Operating income (loss):
 
 
 
 
 
 
 
Consumer Products
$
15,521

 
$
12,535

 
$
44,948

 
$
24,717

Pulp and Paperboard
37,446

 
45,602

 
81,394

 
116,013

 
52,967

 
58,137

 
126,342

 
140,730

Corporate
(12,921
)
 
(14,159
)
 
(38,986
)
 
(43,151
)
Income from operations
$
40,046

 
$
43,978

 
$
87,356

 
$
97,579

 
 
 
 
 
 
 
 
Depreciation and amortization:
 
 
 
 
 
 
 
Consumer Products
$
14,048

 
$
15,484

 
$
40,463

 
$
46,045

Pulp and Paperboard
6,535

 
5,939

 
20,583

 
18,228

Corporate
621

 
870

 
1,798

 
2,266

Total depreciation and amortization
$
21,204

 
$
22,293

 
$
62,844

 
$
66,539


15



NOTE 15 Supplemental Guarantor Financial Information
All of our direct and indirect subsidiaries guarantee the 2014 Notes and the 2013 Notes on a joint and several basis. There are no significant restrictions on the ability of the guarantor subsidiaries to make distributions to Clearwater Paper, the issuer of the 2014 Notes and 2013 Notes. The following tables present the results of operations, financial position and cash flows of Clearwater Paper and its subsidiaries, the guarantor and non-guarantor entities, and the eliminations necessary to arrive at the information for Clearwater Paper on a consolidated basis.
Clearwater Paper Corporation
Consolidating Statement of Operations and Comprehensive Income (Loss)
Three Months Ended September 30, 2015
 
 
 
Guarantor
 
Non-Guarantor
 
 
 
 
(In thousands)
Issuer
 
Subsidiaries
 
Subsidiary
 
Eliminations
 
Total
Net sales
$
450,055

 
$
77,261

 
$

 
$
(85,094
)
 
$
442,222

Cost and expenses:
 
 
 
 
 
 
 
 
 
Cost of sales
(393,237
)
 
(65,749
)
 

 
85,094

 
(373,892
)
Selling, general and administrative expenses
(25,130
)
 
(3,154
)
 

 

 
(28,284
)
Total operating costs and expenses
(418,367
)
 
(68,903
)
 

 
85,094

 
(402,176
)
Income from operations
31,688

 
8,358

 

 

 
40,046

Interest expense, net
(7,847
)
 
(35
)
 

 

 
(7,882
)
Earnings before income taxes
23,841

 
8,323

 

 

 
32,164

Income tax (provision) benefit
(4,616
)
 
153

 

 
(4,637
)
 
(9,100
)
Equity in income of subsidiary
8,476

 

 

 
(8,476
)
 

Net earnings
$
27,701

 
$
8,476

 
$

 
$
(13,113
)
 
$
23,064

Other comprehensive income, net of tax
1,601

 

 

 

 
1,601

Comprehensive income
$
29,302

 
$
8,476

 
$

 
$
(13,113
)
 
$
24,665

Clearwater Paper Corporation
Consolidating Statement of Operations and Comprehensive Income (Loss)
Nine Months Ended September 30, 2015
 
 
 
Guarantor
 
Non-Guarantor
 
 
 
 
(In thousands)
Issuer
 
Subsidiaries
 
Subsidiaries
 
Eliminations
 
Total
Net sales
$
1,246,886

 
$
220,860

 
$

 
$
(146,940
)
 
$
1,320,806

Cost and expenses:
 
 
 
 
 
 
 
 
 
Cost of sales
(1,086,997
)
 
(208,014
)
 

 
146,940

 
(1,148,071
)
Selling, general and administrative expenses
(75,349
)
 
(10,030
)
 

 

 
(85,379
)
Total operating costs and expenses
(1,162,346
)
 
(218,044
)
 

 
146,940

 
(1,233,450
)
Income from operations
84,540

 
2,816

 

 

 
87,356

Interest expense, net
(23,329
)
 
(109
)
 

 

 
(23,438
)
Earnings before income taxes
61,211

 
2,707

 

 

 
63,918

Income tax provision
(17,525
)
 
(1,030
)
 

 
(945
)
 
(19,500
)
Equity in income of subsidiary
1,677

 

 

 
(1,677
)
 

Net earnings
$
45,363

 
$
1,677

 
$

 
$
(2,622
)
 
$
44,418

Other comprehensive income, net of tax
4,802

 

 

 

 
4,802

Comprehensive income
$
50,165

 
$
1,677

 
$

 
$
(2,622
)
 
$
49,220


16



Clearwater Paper Corporation
Consolidating Statement of Operations and Comprehensive Income (Loss)
Three Months Ended September 30, 2014
 
 
 
Guarantor
 
Non-Guarantor
 
 
 
 
(In thousands)
Issuer
 
Subsidiaries
 
Subsidiary
 
Eliminations
 
Total
Net sales
$
415,175

 
$
132,797

 
$
14,429

 
$
(51,259
)
 
$
511,142

Cost and expenses:
 
 
 
 
 
 
 
 
 
Cost of sales
(345,825
)
 
(126,547
)
 
(13,344
)
 
51,259

 
(434,457
)
Selling, general and administrative expenses
(26,136
)
 
(5,343
)
 
(338
)
 

 
(31,817
)
Impairment of assets

 
(890
)
 

 

 
(890
)
Total operating costs and expenses
(371,961
)
 
(132,780
)
 
(13,682
)
 
51,259

 
(467,164
)
Income from operations
43,214

 
17

 
747

 

 
43,978

Interest expense, net
(9,565
)
 
(5
)
 

 

 
(9,570
)
Debt retirement costs
(24,420
)
 

 

 

 
(24,420
)
Earnings before income taxes
9,229

 
12

 
747

 

 
9,988

Income tax (provision) benefit
(5,489
)
 
90

 
(189
)
 
1,853

 
(3,735
)
Equity in income of subsidiary
660

 
558

 

 
(1,218
)
 

Net earnings
$
4,400

 
$
660

 
$
558

 
$
635

 
$
6,253

Other comprehensive income, net of tax
1,201

 

 

 

 
1,201

Comprehensive income
$
5,601

 
$
660

 
$
558

 
$
635

 
$
7,454


Clearwater Paper Corporation
Consolidating Statement of Operations and Comprehensive Income (Loss)
Nine Months Ended September 30, 2014
 
 
 
Guarantor
 
Non-Guarantor
 
 
 
 
(In thousands)
Issuer
 
Subsidiaries
 
Subsidiaries
 
Eliminations
 
Total
Net sales
$
1,201,662

 
$
405,442

 
$
41,493

 
$
(153,776
)
 
$
1,494,821

Cost and expenses:
 
 
 
 
 
 
 
 
 
Cost of sales
(1,006,119
)
 
(403,750
)
 
(39,104
)
 
153,776

 
(1,295,197
)
Selling, general and administrative expenses
(79,702
)
 
(16,180
)
 
(1,014
)
 

 
(96,896
)
Impairment of assets

 
(5,149
)
 

 

 
(5,149
)
Total operating costs and expenses
(1,085,821
)
 
(425,079
)
 
(40,118
)
 
153,776

 
(1,397,242
)
Income (loss) from operations
115,841

 
(19,637
)
 
1,375

 

 
97,579

Interest expense, net
(30,969
)
 
(23
)
 

 

 
(30,992
)
Debt retirement costs
(24,420
)
 

 

 

 
(24,420
)
Earnings (loss) before income taxes
60,452

 
(19,660
)
 
1,375

 

 
42,167

Income tax (provision) benefit
(26,238
)
 
3,787

 
(373
)
 
5,589

 
(17,235
)
Equity in (loss) income of subsidiary
(14,871
)
 
1,002

 

 
13,869

 

Net earnings (loss)
$
19,343

 
$
(14,871
)
 
$
1,002

 
$
19,458

 
$
24,932

Other comprehensive income, net of tax
3,605

 

 

 

 
3,605

Comprehensive income (loss)
$
22,948

 
$
(14,871
)
 
$
1,002

 
$
19,458

 
$
28,537


17



Clearwater Paper Corporation
Consolidating Balance Sheet
At September 30, 2015
 
(In thousands)
Issuer
 
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiary
 
Eliminations
 
Total
ASSETS
 
 
 
 
 
 
 
 
 
Current assets:
 
 
 
 
 
 
 
 
 
Cash
$
13,417

 
$

 
$

 
$

 
$
13,417

Restricted cash
2,270

 

 

 

 
2,270

Short-term investments
10,000

 

 

 

 
10,000

Receivables, net
134,412

 
19,445

 

 

 
153,857

Inventories
222,965

 
38,718

 

 

 
261,683

Deferred tax assets
17,921

 
2,666

 

 
(257
)
 
20,330

Prepaid expenses
6,247

 
516

 

 

 
6,763

Total current assets
407,232

 
61,345

 

 
(257
)
 
468,320

Property, plant and equipment, net
691,086

 
145,672

 

 

 
836,758

Goodwill
209,087

 

 

 

 
209,087

Intangible assets, net
4,440

 
16,791

 

 

 
21,231

Intercompany receivable (payable)
25,121

 
(25,378
)
 

 
257

 

Investment in subsidiary
138,959

 

 

 
(138,959
)
 

Pension assets
8,743

 

 

 

 
8,743

Other assets, net
6,398

 
996

 

 

 
7,394

TOTAL ASSETS
$
1,491,066

 
$
199,426

 
$

 
$
(138,959
)
 
$
1,551,533

LIABILITIES AND STOCKHOLDERS’
  EQUITY
 
 
 
 
 
 
 
 
 
Current liabilities:
 
 
 
 
 
 
 
 
 
Accounts payable and accrued
  liabilities
$
221,191

 
$
23,762

 
$

 
$

 
$
244,953

Current liability for pensions and
  other postretirement employee
  benefits
7,915

 

 

 

 
7,915

Total current liabilities
229,106

 
23,762

 

 

 
252,868

Long-term debt
575,000

 

 

 

 
575,000

Liability for pensions and other
  postretirement employee benefits
113,531

 

 

 

 
113,531

Other long-term obligations
47,068

 
628

 

 

 
47,696

Accrued taxes
776

 
797

 

 

 
1,573

Deferred tax liabilities
65,604

 
35,280

 

 

 
100,884

Accumulated other comprehensive loss,
  net of tax
(66,061
)
 

 

 

 
(66,061
)
Stockholders’ equity excluding
  accumulated other comprehensive loss
526,042

 
138,959

 

 
(138,959
)
 
526,042

TOTAL LIABILITIES AND
  STOCKHOLDERS’ EQUITY
$
1,491,066

 
$
199,426

 
$

 
$
(138,959
)
 
$
1,551,533



18



Clearwater Paper Corporation
Consolidating Balance Sheet
At December 31, 2014
 
(In thousands)
Issuer
 
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiary
 
Eliminations
 
Total
ASSETS
 
 
 
 
 
 
 
 
 
Current assets:
 
 
 
 
 
 
 
 
 
Cash
$
27,331

 
$

 
$

 
$

 
$
27,331

Restricted cash
1,500

 

 

 

 
1,500

Short-term investments
50,000

 

 

 

 
50,000

Receivables, net
117,970

 
16,557

 

 
(613
)
 
133,914

Taxes receivable
6,760

 
(15,758
)
 

 
10,253

 
1,255

Inventories
246,210

 
40,416

 

 

 
286,626

Deferred tax assets
14,733

 
5,206

 

 
1,821

 
21,760

Prepaid expenses
3,734

 
457

 

 

 
4,191

Total current assets
468,238

 
46,878

 

 
11,461

 
526,577

Property, plant and equipment, net
657,369

 
153,618

 

 

 
810,987

Goodwill
209,087

 

 

 

 
209,087

Intangible assets, net
5,224

 
19,732

 

 

 
24,956

Intercompany receivable (payable)
33,703

 
(21,629
)
 

 
(12,074
)
 

Investment in subsidiary
137,282

 

 

 
(137,282
)
 

Pension assets
4,738

 

 

 

 
4,738

Other assets, net
8,496

 
1,087

 

 

 
9,583

TOTAL ASSETS
$
1,524,137

 
$
199,686

 
$

 
$
(137,895
)
 
$
1,585,928

LIABILITIES AND STOCKHOLDERS’
  EQUITY
 
 
 
 
 
 
 
 
 
Current liabilities:
 
 
 
 
 
 
 
 
 
Accounts payable and accrued
  liabilities
$
193,326

 
$
23,113

 
$

 
$
(613
)
 
$
215,826

Current liability for pensions and
  other postretirement employee
  benefits
7,915

 

 

 

 
7,915

Total current liabilities
201,241

 
23,113

 

 
(613
)
 
223,741

Long-term debt
575,000

 

 

 

 
575,000

Liability for pensions and other
  postretirement employee benefits
118,464

 

 

 

 
118,464

Other long-term obligations
56,029

 
827

 

 

 
56,856

Accrued taxes
1,902

 
794

 

 

 
2,696

Deferred tax liabilities
73,964

 
37,670

 

 

 
111,634

Accumulated other comprehensive loss,
  net of tax
(70,863
)
 

 

 

 
(70,863
)
Stockholders’ equity excluding
  accumulated other comprehensive loss
568,400

 
137,282

 

 
(137,282
)
 
568,400

TOTAL LIABILITIES AND
  STOCKHOLDERS’ EQUITY
$
1,524,137

 
$
199,686

 
$

 
$
(137,895
)
 
$
1,585,928



19



Clearwater Paper Corporation
Consolidating Statement of Cash Flows
Nine Months Ended September 30, 2015
 
(In thousands)
Issuer
 
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiary
 
Eliminations
 
Total
CASH FLOWS FROM OPERATING
  ACTIVITIES
 
 
 
 
 
 
 
 
 
Net earnings
$
45,363

 
$
1,677

 
$

 
$
(2,622
)
 
$
44,418

Adjustments to reconcile net earnings to
  net cash flows from operating activities:
 
 
 
 
 
 
 
 
 
Depreciation and amortization
47,854

 
14,990

 

 

 
62,844

Equity-based compensation expense
2,495

 

 

 

 
2,495

Deferred tax (benefit) provision
(14,631
)
 
150

 

 
2,078

 
(12,403
)
Employee benefit plans
2,122

 

 

 

 
2,122

Deferred issuance costs and discounts on
  long-term debt
714

 

 

 

 
714

Disposal of plant and equipment, net
1,203

 
(94
)
 

 

 
1,109

Non-cash adjustments to unrecognized taxes
(1,126
)
 
3

 

 

 
(1,123
)
Changes in working capital, net
15,656

 
(185
)
 

 

 
15,471

Changes in taxes receivable, net
6,760

 
(15,758
)
 

 
10,253

 
1,255

Excess tax benefits from equity-based
  payment arrangements
(3,848
)
 

 

 

 
(3,848
)
Funding of qualified pension plans
(3,179
)
 

 

 

 
(3,179
)
Other, net
(1,261
)
 
(1,059
)
 

 

 
(2,320
)
Net cash flows from operating activities
98,122

 
(276
)
 

 
9,709

 
107,555

CASH FLOWS FROM INVESTING
  ACTIVITIES
 
 
 
 
 
 
 
 
 
Changes in short-term investments, net
40,000

 

 

 

 
40,000

Additions to plant and equipment
(74,002
)
 
(4,459
)
 

 

 
(78,461
)
Proceeds from sale of assets

 
587

 

 

 
587

Net cash flows from investing activities
(34,002
)
 
(3,872
)
 

 

 
(37,874
)
CASH FLOWS FROM FINANCING
  ACTIVITIES
 
 
 
 
 
 
 
 
 
Purchase of treasury stock
(84,305
)
 

 

 

 
(84,305
)
Investment from parent
5,561

 
4,148

 

 
(9,709
)
 

Payment of tax withholdings on equity-
  based payment arrangements
(3,129
)
 

 

 

 
(3,129
)
Excess tax benefits from equity-based
  payment arrangements
3,848

 

 

 

 
3,848

Other, net
(9
)
 

 

 

 
(9
)
Net cash flows from financing activities
(78,034
)
 
4,148

 

 
(9,709
)
 
(83,595
)
Decrease in cash
(13,914
)
 

 

 

 
(13,914
)
Cash at beginning of period
27,331

 

 

 

 
27,331

Cash at end of period
$
13,417

 
$

 
$

 
$

 
$
13,417


20



Clearwater Paper Corporation
Consolidating Statement of Cash Flows
Nine Months Ended September 30, 2014
(In thousands)
Issuer
 
Guarantor Subsidiaries
 
Non-Guarantor
Subsidiary
 
Eliminations
 
Total
CASH FLOWS FROM OPERATING
  ACTIVITIES
 
 
 
 
 
 
 
 
 
Net earnings (loss)
$
19,343

 
$
(14,871
)
 
$
1,002

 
$
19,458

 
$
24,932

Adjustments to reconcile net earnings (loss) to net
  cash flows from operating activities:
 
 
 
 
 
 
 
 
 
Depreciation and amortization
43,388

 
21,416

 
1,735

 

 
66,539

Equity-based compensation expense
9,201

 

 

 

 
9,201

Impairment of assets

 
5,149

 

 

 
5,149

Deferred tax provision (benefit)
31,563

 
(6,516
)
 
(32
)
 
(12,120
)
 
12,895

Employee benefit plans
1,603

 

 

 

 
1,603

Deferred issuance costs and discounts on
  long-term debt
5,864

 

 

 

 
5,864

Disposal of plant and equipment, net
462

 
285

 

 

 
747

Non-cash adjustments to unrecognized taxes
220

 
(60
)
 
(11
)
 

 
149

Changes in working capital, net
(15,079
)
 
4,464

 
(2,575
)
 

 
(13,190
)
Changes in taxes receivable, net
2,493

 
(12,730
)
 
99

 
18,032

 
7,894

Excess tax benefit from equity-based
  payment arrangements
(1,508
)
 

 

 

 
(1,508
)
Funding of qualified pension plans
(15,957
)
 

 

 

 
(15,957
)
Other, net
(1,947
)
 
(440
)
 

 

 
(2,387
)
Net cash flows from operating activities
79,646

 
(3,303
)
 
218

 
25,370

 
101,931

CASH FLOWS FROM INVESTING
  ACTIVITIES
 
 
 
 
 
 
 
 
 
Changes in short-term investments, net
70,000

 

 

 

 
70,000

Additions to plant and equipment
(42,478
)
 
(11,330
)
 
(221
)
 

 
(54,029
)
Proceeds from sale of assets
38

 
695

 

 

 
733

Net cash flows from investing activities
27,560

 
(10,635
)
 
(221
)
 

 
16,704

CASH FLOWS FROM FINANCING
  ACTIVITIES
 
 
 
 
 
 
 
 
 
Proceeds from long-term debt
300,000

 

 

 

 
300,000

Repayment of long-term debt
(375,000
)
 

 

 

 
(375,000
)
Purchase of treasury stock
(100,000
)
 

 

 

 
(100,000
)
Investment from (to) parent
14,482

 
13,938

 
(3,050
)
 
(25,370
)
 

Change in short-term borrowings, net
47,047

 

 

 

 
47,047

Payments for long-term debt issuance costs
(2,995
)
 

 

 

 
(2,995
)
Payment of tax withholdings on equity-
  based payment arrangements
(792
)
 

 

 

 
(792
)
Excess tax benefit from equity-based
  payment arrangements
1,508

 

 

 

 
1,508

Other, net
1,500

 

 

 

 
1,500

Net cash flows from financing activities
(114,250
)
 
13,938

 
(3,050
)
 
(25,370
)
 
(128,732
)
Decrease in cash
(7,044
)
 

 
(3,053
)
 

 
(10,097
)
Cash at beginning of period
18,273

 

 
5,402

 

 
23,675

Cash at end of period
$
11,229

 
$

 
$
2,349

 
$

 
$
13,578



21



ITEM 2.
 
Management’s Discussion and Analysis of Financial Condition and Results of Operations
FORWARD-LOOKING STATEMENTS
Our disclosure and analysis in this report contains, in addition to historical information, certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding benefit plan funding, the costs and costs savings benefits associated with the closure of our Long Island, New York facility, the costs, timing and benefits associated with strategic capital investments including our continuous pulp digester project, tax rates, cash flows, energy costs, and interest expenses. Words such as “anticipate,” “expect,” “intend,” “plan,” “target,” “project,” “believe,” “schedule,” “estimate,” “may,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements are based on management’s current expectations, estimates, assumptions and projections that are subject to change. Our actual results of operations may differ materially from those expressed or implied by the forward-looking statements contained in this report. Important factors that could cause or contribute to such differences include those risks discussed in the section entitled “Risk Factors” in our 2014 Form 10-K, as well as the following:
competitive pricing pressures for our products, including as a result of increased capacity as additional manufacturing facilities are operated by our competitors;
customer acceptance, timing and quantity of purchases of our new through-air-dried, or TAD, products or other tissue products;
changes in the U.S. and international economies and in general economic conditions in the regions and industries in which we operate;
the loss of or changes in prices in regards to a significant customer;
announced price increases for our products may not be accepted in whole or part;
changes in transportation costs and disruptions in transportation services;
manufacturing or operating disruptions, including IT system and IT system implementation failures, equipment malfunction and damage to our manufacturing facilities caused by fire or weather-related events;
changes in the cost and availability of wood fiber and wood pulp;
labor disruptions;
changes in costs for and availability of packaging supplies, chemicals, energy and maintenance and repairs;
cyclical industry conditions;
changes in customer product preferences and competitors' product offerings;
changes in expenses and required contributions associated with our pension plans;
reliance on a limited number of third-party suppliers for raw materials;
environmental liabilities or expenditures;
inability to successfully implement our operational efficiencies and expansion strategies;
inability to fund our debt obligations;
restrictions on our business from debt covenants and terms; and
changes in laws, regulations or industry standards affecting our business.
Forward-looking statements contained in this report present management’s views only as of the date of this report. Except as required under applicable law, we do not intend to issue updates concerning any future revisions of management’s views to reflect events or circumstances occurring after the date of this report.

22



OVERVIEW
Background
Clearwater Paper manufactures quality consumer tissue, away-from-home tissue, parent roll tissue, bleached paperboard and pulp at manufacturing facilities across the nation. The company is a premier supplier of private label tissue to major retailers and wholesale distributors, including grocery, drug, mass merchants and discount stores. In addition, the company produces bleached paperboard used by quality-conscious printers and packaging converters. Clearwater Paper's employees build shareholder value by developing strong customer partnerships through quality and service.
Recent Developments
Strategic Capital Projects
As part of our focus on strategic capital spending on projects that we expect to provide a positive return on investments, we announced on September 8, 2015 the construction of a continuous pulp digester project at our Lewiston, Idaho, pulp and paperboard facility. We estimate that the total cost for this pulp optimization project will be approximately $150-$160 million, excluding estimated capitalized interest. We expect to spend approximately $26 million on this project in 2015, approximately $61 million in 2016 and the remaining balance thereafter. The project’s construction is slated to begin in 2015, and is expected to be completed in the second half of 2017. We anticipate that this project will significantly reduce air emissions, improve pulp quality and production and enable efficient utilization of wood chips.
Mill Divestitures and Facility Closures
On December 30, 2014, we sold our specialty business and mills to a private buyer for $108 million in cash, net of sale related expenses and adjustments. The specialty business and mills' production consisted predominantly of machine-glazed tissue and also included parent rolls and other specialty tissue products such as absorbent materials and dark-hued napkins. The sale included five of our former subsidiaries with facilities located at East Hartford, Connecticut; Menominee, Michigan; Gouverneur, New York; St. Catharines, Ontario; and Wiggins, Mississippi. Included in the sale related expenses and adjustments was the impact of certain indemnity and working capital escrow clauses in the sales agreement. These escrowed amounts totaled $3.8 million of restricted cash on our December 31, 2014 Consolidated Balance Sheet. During the second quarter of 2015, the working capital escrow account established in connection with the sale of the specialty business and mills was settled, resulting in the release of $1.5 million from the restricted cash escrow account and the recognition of a corresponding gain recorded in "Selling, general and administrative expenses" within our Consolidated Statement of Operations.
On February 17, 2014, we announced the permanent and immediate closure of our Long Island, New York, tissue converting and distribution facility. As of September 30, 2015, we have incurred $20.8 million of costs associated with the closure, of which $0.7 million and $2.0 million, respectively, were incurred during the three and nine month periods ended September 30, 2015. We expect that the remaining costs to be incurred in 2015 will be less than $1 million. The cost savings benefits resulting from the Long Island facility consolidation and optimization are expected to be approximately $12 million on an annual basis.
Capital Allocation
On December 15, 2014, we announced that our Board of Directors had approved a new stock repurchase program authorizing the repurchase of up to $100 million of our common stock. The repurchase program authorized purchases of our common stock from time to time through open market purchases, negotiated transactions or other means, including accelerated stock repurchases and 10b5-1 trading plans in accordance with applicable securities laws and other restrictions. In total, we repurchased 1,750,808 shares of our outstanding common stock as of September 30, 2015, pursuant to this repurchase program, of which 1,151,313 shares were repurchased during the third quarter of 2015 at an average price of $49.23 per share. As of September 30, 2015, we had up to $6.2 million of authorization remaining pursuant to this stock repurchase program. Subsequent to the close of our third quarter ended September 30, 2015, we repurchased an additional 131,113 shares of our outstanding common stock at an average price of $46.97 per share, which completed the remainder of this repurchase program.
On July 29, 2014, we issued $300 million of aggregate principal amount senior notes, which we refer to as the 2014 Notes. The 2014 Notes mature on February 1, 2025, have an interest rate of 5.375% and were issued at their face value. All of the net proceeds from the issuance, as well as company funds and short-term borrowings from our senior secured revolving credit facility, were used to redeem all of our $375 million aggregate principal amount of 7.125% senior notes due 2018, which we refer to as the 2010 Notes.
On February 5, 2014, we announced that our Board of Directors had approved a stock repurchase program authorizing the repurchase of up to $100 million of our common stock. We completed that program during the third quarter of 2014. In total, we repurchased 1,574,748 shares of our outstanding common stock at an average price of $63.50 per share under that program.

23



Components and Trends in our Business
Net sales
Net sales predominantly consist of sales of consumer tissue and paperboard products, net of discounts, returns and allowances and any sales taxes collected. Prices for our consumer tissue products tend to be primarily driven by the value of our products to our customers, and are generally priced relative to the prices of branded tissue products. Demand and pricing for our pulp and paperboard products are largely determined by general global market conditions and the demand for high quality paperboard.
Operating costs
  
Three Months Ended September 30,
(Dollars in thousands)
2015
 
2014
  
Cost
 
Percentage of
Cost of Sales
 
Cost3
 
Percentage of
Cost of Sales3
Purchased pulp
$
45,657

 
12.2
%
 
$
73,902

 
17.0
%
Transportation1
48,808

 
13.1

 
50,266

 
11.6

Chemicals
45,285

 
12.1

 
54,014

 
12.4

Chips, sawdust and logs
35,502

 
9.5

 
40,441

 
9.3

Energy
27,279

 
7.3

 
33,819

 
7.8

Maintenance and repairs2
19,120

 
5.1

 
18,633

 
4.3

Packaging supplies
23,259

 
6.2

 
26,449

 
6.1

Depreciation
19,286

 
5.2

 
19,724

 
4.5

 
$
264,196

 
70.7
%
 
$
317,248

 
73.0
%
 
 
 
 
 
 
 
 
 
Nine Months Ended September 30,
(Dollars in thousands)
2015
 
2014
 
Cost
 
Percentage of
Cost of Sales
 
Cost3
 
Percentage of
Cost of Sales
3
Purchased pulp
$
138,486

 
12.1
%
 
$
223,112

 
17.2
%
Transportation1
137,387

 
12.0

 
142,702

 
11.0

Chemicals
136,899

 
11.9

 
153,453

 
11.9

Chips, sawdust and logs
110,128

 
9.6

 
111,294

 
8.6

Energy
83,578

 
7.3

 
104,953

 
8.1

Maintenance and repairs2
74,849

 
6.5

 
59,759

 
4.6

Packaging supplies
71,092

 
6.1

 
76,424

 
5.9

Depreciation
56,986

 
5.0

 
59,107

 
4.6

 
$
809,405

 
70.5
%
 
$
930,804

 
71.9
%
1
Includes internal and external transportation costs.
2
Excluding related labor costs.
3
Results include the specialty business and mills, which were sold in December 2014.

Purchased pulp. We purchase a significant amount of the pulp needed to manufacture our consumer products, and to a lesser extent our paperboard, from external suppliers. For the three and nine months ended September 30, 2015, total purchased pulp costs decreased by $28.2 million and $84.6 million, respectively, compared to the same periods in 2014, as a direct result of the sale of our former specialty business and mills in December 2014. Excluding pulp costs associated with the specialty business and mills, purchased pulp costs were slightly higher during the three and nine months ended September 30, 2015. The increase for the nine month period ended September 30, 2015 was due primarily to increased purchased pulp during the first half of 2015 due to the scheduled major maintenance outages taken at our Idaho and Arkansas pulp and paperboard facilities. This increase was partially offset by favorable external pulp pricing and a higher utilization of internally sourced pulp when compared to the same periods of 2014.
Transportation. Fuel prices, mileage driven and line-haul rates largely impact transportation costs for the delivery of raw materials to our manufacturing facilities, internal inventory transfers and the delivery of our finished products to customers. Changing fuel prices particularly affect our margins for consumer products because we supply customers throughout the U.S. and transport unconverted parent rolls from our tissue mills to our tissue converting facilities. Our transportation costs for the three and nine months ended September 30, 2015, decreased $1.5 million and $5.3 million, respectively, compared to the same periods in 2014, primarily due to the sale of our specialty business and mills, as discussed above. Excluding transportation costs associated with

24



the specialty business and mills, transportation costs during the three and nine months ended September 30, 2015 were flat and slightly lower, respectively, when compared to the same periods of 2014. In the first quarter of 2015, we improved inventory levels and implemented network optimization measures, which resulted in fewer internal transfers and miles per shipment and lower overall transportation costs. These improvements more than offset higher line-haul rates and increases in carrier costs in the first nine months of 2015 primarily attributable to tighter carrier supply. The comparable 2014 nine month period also had higher fuel prices and extreme cold weather conditions in the Midwest and Northeast that negatively affected carrier costs in the first quarter of 2014 by limiting vendor availability.
Chemicals. We consume a substantial amount of chemicals in the production of pulp and paperboard, as well as in the production of TAD tissue. The chemicals we generally use include polyethylene, caustic, starch, sodium chlorate, latex and paper processing chemicals. A portion of the chemicals used in our manufacturing processes, particularly in the paperboard extrusion process, are petroleum based and are impacted by petroleum prices.
Our chemical costs decreased $8.7 million and $16.6 million, respectively, during the three and nine months ended September 30, 2015, primarily due to lower usage resulting from the sale of our specialty business and mills. Excluding chemical costs associated with the specialty mills, chemical costs for the three and nine months ended September 30, 2015 decreased $4.0 million and $4.4 million, respectively, compared to the same periods in 2014. These favorable comparisons were primarily due to decreased pricing for polyethylene and other paper making chemicals, as well as lower consumption for the nine month period due to the scheduled major maintenance downtime at our pulp and paperboard facilities in the first half of 2015. In addition, the comparable 2014 nine month period had higher chemical costs due to operational issues at our Arkansas pulp and paperboard facility that caused both the pulp mill and paper machine to consume elevated levels of chemicals.
Chips, sawdust and logs. We purchase chips, sawdust and logs to manufacture pulp. We source residual wood fibers under both long-term and short-term supply agreements, as well as in the spot market. Overall costs for chips, sawdust and logs for the three and nine months ended September 30, 2015 decreased $4.9 million and $1.2 million, respectively, compared to the same periods in 2014. The decreases were due primarily to lower chip pricing at our Idaho and Arkansas pulp and paperboard facilities. Additionally, costs for the third quarter of 2015 were lower due to decreased paperboard production associated with a decline in shipments compared to the same period in 2014.
Energy. We use energy in the form of electricity, hog fuel, steam and natural gas to operate our mills. Energy prices may fluctuate widely from period-to-period due primarily to volatility in weather and electricity and natural gas rates. We generally strive to reduce our exposure to volatile energy prices through conservation. In addition, a cogeneration facility that produces steam and electricity at our Lewiston, Idaho manufacturing site helps to lower our energy costs. TAD tissue production involves increased natural gas usage compared to conventional tissue manufacturing and, as a result, our natural gas requirements have increased in connection with the increase of production from our North Carolina TAD paper machine.
Energy costs for the three and nine months ended September 30, 2015, were $6.5 million and $21.4 million lower, respectively, than those for the same periods in 2014 due largely to lower usage resulting from the sale of our specialty business and mills. Excluding energy costs associated with the specialty mills, energy costs decreased $0.4 million and $1.0 million, respectively, during the three and nine months ended September 30, 2015. The decrease for the three month period was due primarily to lower natural gas pricing. For the nine month period, in addition to lower natural gas pricing, energy costs decreased as a result of lower usage at many of our facilities due primarily to the absence of the extremely cold weather conditions in the Midwest and Northeast that occurred during the first quarter of 2014, as well as the absence of operational issues at our Arkansas facility that occurred during the first nine months of 2014.
To help mitigate our exposure to changes in natural gas prices, we use firm-price contracts to supply a portion of our natural gas requirements. As of September 30, 2015, these contracts covered approximately 51% of our expected average monthly natural gas requirements for the remainder of 2015, plus lesser amounts for 2016. Our energy costs in future periods will depend principally on our ability to produce a substantial portion of our electricity needs internally, on changes in market prices for natural gas and on our ability to reduce our energy usage through conservation.
Maintenance and repairs. We regularly incur significant costs to maintain our manufacturing equipment. We perform routine maintenance on our machines and periodically replace a variety of parts such as motors, pumps, pipes and electrical parts.
Major equipment maintenance and repairs in our Pulp and Paperboard segment also require maintenance shutdowns approximately every 18 months to 24 months at both our Idaho and Arkansas facilities, which increase costs and may reduce net sales in the quarters in which the major maintenance shutdowns occur. During the first quarter of 2015, we had eleven days of paper machine downtime at our Idaho facility at a cost of approximately $15 million. During the second quarter of 2015, we had four days of paper machine downtime at our Arkansas facility at a cost of approximately $7 million. We did not have any major maintenance outages during the third quarter of 2015, nor did we have any major maintenance outages during the first three quarters of 2014.
In addition to ongoing maintenance and repair costs, we make capital expenditures to increase our operating capacity and efficiency, improve safety at our facilities and comply with environmental laws. For example, on September 8, 2015 we announced a strategic capital spending project at our Lewiston facility with an estimated $150-$160 million cost, excluding capitalized interest. During

25



the three and nine months ended September 30, 2015, excluding capitalized interest, we spent $33.2 million and $83.4 million, respectively, on capital expenditures, which includes $22.1 million and $40.0 million, respectively, of strategic capital spending on projects designed to reduce future manufacturing costs and provide a positive return on investment. During the three and nine months ended September 30, 2014, we spent $26.2 million and $57.9 million, respectively, on capital expenditures.
Packaging supplies. As a significant producer of private label consumer tissue products, we package to order for retail chains, wholesalers and cooperative buying organizations. Under our agreements with those customers, we are responsible for the expenses related to the unique packaging of our products for direct retail sale to their consumers. For the three and nine months ended September 30, 2015, packaging costs decreased $3.2 million and $5.3 million, respectively, compared to the same periods in 2014 due largely to lower production resulting from the sale of our specialty business and mills. Excluding packaging costs associated with the specialty mills, packaging costs for the three and nine months ended September 30, 2015 decreased $2.0 million and $2.1 million, respectively, compared to the same periods in 2014, due to lower case sales and favorable pricing for packaging supplies.
Depreciation. We record substantially all of our depreciation expense associated with our plant and equipment in "Cost of sales" on our Consolidated Statements of Operations. Depreciation expense for the three and nine months ended September 30, 2015, decreased $0.4 million and $2.1 million, respectively, compared to the same periods in 2014, primarily as a result of the sale of our specialty business and mills, as well as the closure of our Long Island facility, partially offset by increased depreciation related to capital spending during recent periods.
Other. Other costs not included in the above table primarily consist of wage and benefit expenses and miscellaneous operating costs. Although period cut-offs can impact cost of sales amounts, we would expect this impact to be relatively steady as a percentage of costs on a period-over-period basis. We experienced lower wage and benefit expenses during the three and nine months ended September 30, 2015, compared to the same periods in 2014, due to the sale of our specialty business and mills and the closure of our Long Island facility, which for the nine month period of 2015 were partially offset by $1.7 million of costs associated with a new collective bargaining agreement at our consumer products and pulp and paperboard facilities in Lewiston, Idaho.
Selling, general and administrative expenses
Selling, general and administrative expenses primarily consist of compensation and associated expenses for sales and administrative personnel, as well as commission expenses related to sales of our products. Our selling, general and administrative expenses for the third quarters of 2015 and 2014 were $28.3 million and $31.8 million, respectively. The lower expense was primarily a result of reduced headcount and administrative costs related to the sale of the specialty business and mills, as well as a $1.9 million mark-to-market benefit during the third quarter of 2015, compared to a minimal mark-to-market adjustment in the third quarter of 2014, related to our directors' common stock units, which will ultimately be settled in cash. These decreases were partially offset by $2.0 million of non-routine legal expenses and settlement costs, including those related to a dispute involving one of our closed facilities, as well as $1.1 million of reorganization related expenses.
Interest expense
Interest expense for the nine months ended September 30, 2015 includes interest on our $275 million aggregate principal amount of 4.5% senior notes due 2023 issued in January 2013, which we refer to as the 2013 Notes, and interest on our 2014 Notes. Interest expense for the nine months ended September 30, 2014 includes interest on our 2013 Notes, partial interest on our former 2010 Notes, partial interest on our 2014 Notes, and interest on short-term borrowings from our revolving credit facility. Interest expense for both nine month periods also includes amortization of deferred issuance costs associated with all of our notes and our revolving credit facility. As a result of the issuance of the 2014 Notes at an interest rate lower than that of our former 2010 Notes, interest expense in the first nine months of 2015 was lower than the same period of 2014.
Income taxes
Income taxes are based on reported earnings and tax rates in the jurisdictions in which our operations occur and offices are located, adjusted for available credits, changes in valuation allowances and differences between reported earnings and taxable income using current tax laws and rates. We generally expect our effective income tax rate, excluding discrete items, to remain fairly constant, although it could fluctuate due to changes in tax law.
During the three and nine month periods ended September 30, 2015, we recorded discrete benefits for the release of valuation allowances on certain state net operating losses. Based upon further review and analysis, we determined these valuation allowances were no longer required, which reduced tax expense by approximately $2 million, or a 5.6% and 2.8% rate reduction for the three and nine month periods ended September 30, 2015, respectively.
During the nine months ended September 30, 2014, we recorded discrete expense for a reduction in our blended state tax rate, as well as adjustments to New York state specific deferred items. These changes were due to amendments we made to our New York state return filings as a result of changes in New York state tax laws. In reviewing the changes in the tax laws, we identified that in prior years we had not applied the proper apportionment factor when certain New York state net operating loss carryforwards were generated, which resulted in a $2.9 million overstatement. We corrected this in the second quarter of 2014 by including the overstatement as a discrete item within state rate adjustments due to immateriality.

26



RESULTS OF OPERATIONS
Three Months Ended September 30, 2015 Compared to Three Months Ended September 30, 2014
The following table sets forth data included in our Consolidated Statements of Operations as a percentage of net sales.
 
Three Months Ended September 30,
(Dollars in thousands)
2015
 
2014
Net sales
$
442,222

 
100.0
%
 
$
511,142

 
100.0
%
Costs and expenses:
 
 
 
 
 
 
 
Cost of sales
(373,892
)
 
84.5

 
(434,457
)
 
85.0

Selling, general and administrative expenses
(28,284
)
 
6.4

 
(31,817
)
 
6.2

Impairment of assets

 

 
(890
)
 
0.2

Total operating costs and expenses
(402,176
)
 
90.9

 
(467,164
)
 
91.4

Income from operations
40,046

 
9.1

 
43,978

 
8.6

Interest expense, net
(7,882
)
 
1.8

 
(9,570
)
 
1.9

Debt retirement costs

 

 
(24,420
)
 
4.8

Earnings before income taxes
32,164

 
7.3

 
9,988

 
2.0

Income tax provision
(9,100
)
 
2.1

 
(3,735
)
 
0.7

Net earnings
$
23,064

 
5.2
%
 
$
6,253

 
1.2
%
Net sales—Third quarter 2015 net sales decreased by $68.9 million, or 13.5%, compared to the third quarter of 2014, primarily due to a decline in non-retail shipments as a result of the sale of our specialty business and mills in December 2014. Net sales for the period were also unfavorably impacted by lower shipments and pricing of commodity grade paperboard. These decreases were partially offset by higher average tissue net selling prices during the third quarter of 2015, which were driven by a favorable product mix shift towards higher margin retail tissue sales from lower priced non-retail sales. These items are further discussed below under “Discussion of Business Segments.”
Cost of sales—Cost of sales was 84.5% of net sales for the third quarter of 2015 and 85.0% of net sales for the same period in 2014. Our overall cost of sales were 13.9% lower than the third quarter of 2014, primarily due to the absence during the third quarter of 2015 of costs associated with our former specialty business and mills and $3.9 million of costs in the third quarter of 2014 related to the closure of our Long Island facility compared to $0.7 million of those closure costs in the third quarter of 2015. These favorable comparisons were partially offset by higher planned maintenance and repair costs incurred for our Idaho pulp and paperboard facility during the third quarter of 2015.
Selling, general and administrative expenses—Selling, general and administrative expenses for the third quarter of 2015 decreased $3.5 million compared to the same quarter in 2014 primarily as a result of reduced headcount and administrative costs related to the sale of the specialty business and mills. Additionally, expenses decreased due to a $1.9 million mark-to-market benefit during the third quarter of 2015, compared to a minimal mark-to-market adjustment in the third quarter of 2014, related to our directors' common stock units. These decreases were partially offset by $2.0 million of non-routine legal expenses and settlement costs, including those related to a dispute involving one of our closed facilities, as well as $1.1 million of reorganization related expenses.
Impairment of assets—During the first quarter of 2014, we permanently closed our Long Island converting and distribution facility. As a result of this closure, we assessed both our intangible and long-lived assets for recoverability. During the third quarter of 2014, we reassessed the remaining assets associated with the facility closure and, as a result, recorded an additional $0.9 million non-cash impairment charge to our accompanying Consolidated Statement of Operations.
Interest expense—Interest expense for the third quarter of 2015 decreased by $1.7 million compared to the third quarter of 2014. The decrease was largely attributable to reduced interest rates on our debt as a result of the third quarter 2014 redemption of the 2010 Notes and the issuance of the 2014 Notes with a lower interest rate.
Debt retirement costs—Debt retirement costs include a one-time $24.4 million charge in connection with the redemption of the 2010 Notes on August 28, 2014. These costs were comprised of cash charges of $19.8 million, which consisted of a "make-whole" premium of $17.6 million plus unpaid interest of $2.2 million, and a non-cash charge of $4.6 million related to the write-off of deferred issuance costs.

27



Income tax provision—We recorded an income tax provision of $9.1 million in the three months ended September 30, 2015, compared to $3.7 million in the same period of 2014. The rate determined under generally accepted accounting principles, or GAAP, for the three months ended September 30, 2015 was approximately 28% compared to a rate of approximately 37% for the same period of 2014. The decrease in the rate was the result of the net impact of reporting discrete items, primarily relating to federal and state adjustments to valuation allowances. Based upon further review and analysis, certain state net operating losses were determined to no longer require a valuation allowance, which reduced tax expense during the quarter by approximately $2 million or a 5.6% rate reduction.
During the third quarters of 2015 and 2014, there were a number of items that were included in the calculation of our income tax provision that we do not believe were indicative of our core operating performance. Excluding these items, the adjusted tax rate for the three months ended September 30, 2015 would have been approximately 29% compared to an adjusted rate of approximately 36% for the three months ended September 30, 2014. The following table details these items:
 
Three Months Ended
 
September 30,
(In thousands)
2015
 
2014
Income tax provision
$
(9,100
)
 
$
(3,735
)
Special items, tax impact:
 
 
 
Directors' equity-based compensation benefit
607

 
65

Legal expenses and settlement costs
(626
)
 

Reorganization related expenses
(376
)
 

Costs associated with Long Island facility closure
(231
)
 
(1,698
)
Debt retirement costs

 
(8,643
)
Adjustments associated with optimization and sale of specialty mills

 
(377
)
Costs associated with Thomaston facility closure

 
(15
)
Adjusted income tax provision
$
(9,726
)
 
$
(14,403
)



28



Discussion of Business Segments
Consumer Products
 
Three Months Ended
  
September 30,
(Dollars in thousands - except per ton amounts)
2015
 
2014
Net sales
$
247,039

 
$
306,104

Operating income
15,521

 
12,535

Percent of net sales
6.3
%
 
4.1
%
 
 
 
 
Shipments (short tons)
 
 
 
Non-retail
21,250

 
59,703

Retail
76,856

 
75,363

Total tissue tons
98,106

 
135,066

Converted products cases (in thousands)
13,375

 
14,360

 
 
 
 
Sales price (per short ton)
 
 
 
Non-retail
$
1,530

 
$
1,531

Retail
2,787

 
2,836

Total tissue
$
2,515

 
$
2,259

Our Consumer Products segment's net sales for the third quarter of 2015 decreased $59.1 million compared to the third quarter of 2014 due to lower non-retail shipments resulting from the sale of our specialty business and mills, as well as a decrease in converted products cases sold. These negative factors were partially offset by higher average tissue net selling prices during the third quarter of 2015 resulting from improved product mix after the sale of our specialty business and mills.
Segment operating income for the third quarter of 2015 increased by $3.0 million compared to the third quarter of 2014. The increase in operating income was due primarily to lower energy costs resulting from a decrease in natural gas pricing, lower packaging costs resulting from favorable pricing for packaging supplies and $0.7 million of costs related to the closure of our Long Island facility during the third quarter of 2015 compared to $4.8 million of facility closure costs during the third quarter of 2014.
Pulp and Paperboard
 
Three Months Ended
  
September 30,
(Dollars in thousands - except per ton amounts)
2015
 
2014
Net sales
$
195,183

 
$
205,038

Operating income
37,446

 
45,602

Percent of net sales
19.2
%
 
22.2
%
 
 
 
 
Paperboard shipments (short tons)
198,535

 
201,609

Paperboard sales price (per short ton)
$
979

 
$
1,016

Net sales for the Pulp and Paperboard segment decreased by $9.9 million during the third quarter of 2015, compared to the third quarter of 2014. The decrease was primarily due to a 3.6% decrease in net selling prices resulting from lower demand and pricing pressure for commodity grade paperboard, as well as a 1.5% decrease in paperboard shipments.
Operating income for the segment decreased $8.2 million during the third quarter of 2015, compared to the third quarter of 2014, primarily due to $3.9 million of additional planned maintenance and repair costs incurred at our Idaho facility during the third quarter of 2015 and contractual wage and benefit increases. Those impacts were partially offset by decreased chemical costs resulting from favorable polyethylene pricing and reduced chemical usage resulting from capital improvements to our Arkansas recovery boiler, as well as decreased energy costs due to favorable natural gas pricing.

29



RESULTS OF OPERATIONS
Nine Months Ended September 30, 2015 Compared to Nine Months Ended September 30, 2014
The following table sets forth data included in our Consolidated Statements of Operations as a percentage of net sales.
 
Nine Months Ended September 30,
(Dollars in thousands)
2015
 
2014
Net sales
$
1,320,806

 
100.0
%
 
$
1,494,821

 
100.0
%
Costs and expenses:
 
 
 
 
 
 
 
Cost of sales
(1,148,071
)
 
86.9

 
(1,295,197
)
 
86.6

Selling, general and administrative expenses
(85,379
)
 
6.5

 
(96,896
)
 
6.5

Impairment of assets

 

 
(5,149
)
 
0.3

Total operating costs and expenses
(1,233,450
)
 
93.4

 
(1,397,242
)
 
93.5

Income from operations
87,356

 
6.6

 
97,579

 
6.5

Interest expense, net
(23,438
)
 
1.8

 
(30,992
)
 
2.1

Debt retirement costs

 

 
(24,420
)
 
1.6

Earnings before income taxes
63,918

 
4.8

 
42,167

 
2.8

Income tax provision
(19,500
)
 
1.5

 
(17,235
)
 
1.2

Net earnings
$
44,418

 
3.4

 
$
24,932

 
1.7

Net sales—Net sales for the nine months ended September 30, 2015 decreased by $174.0 million, or 11.6%, compared to the same period of 2014 primarily due to a decline in non-retail shipments as a result of the sale of our specialty business and mills in December 2014, as well as decreases in converted product cases sold and retail tissue shipments. Net sales were also impacted by slightly lower paperboard shipments and pricing compared to the same period in 2014. These items are further discussed below under “Discussion of Business Segments.”
Cost of sales—Cost of sales was 86.9% of net sales for the nine months ended September 30, 2015 and 86.6% of net sales for the same period in 2014. However, our overall cost of sales was 11.4% lower than the nine months ended September 30, 2014, primarily due to the absence of operating costs associated with our former specialty business and mills and incremental costs in the same period of 2014 associated with the extreme cold weather conditions in the Midwest and Northeast and operational issues at our Arkansas pulp and paperboard facility. Additionally, there were $10.8 million of costs incurred in the first nine months of 2014 related to the closure of our Long Island and Thomaston facilities, compared to $2.0 million of costs in the same period of 2015 related to the Long Island facility closure. These favorable comparisons were partially offset by approximately $22 million of planned major maintenance costs incurred at our Idaho and Arkansas pulp and paperboard facilities during the first half of 2015 and $1.7 million of costs in the first half of 2015 associated with a new collective bargaining agreement at our consumer products and pulp and paperboard facilities in Idaho.
Selling, general and administrative expenses—Selling, general and administrative expenses for the nine months ended September 30, 2015 decreased $11.5 million compared to the same period in 2014 primarily due to a $3.8 million mark-to-market benefit during the first nine months of 2015, compared to $2.6 million of mark-to-market expense in the same period of 2014, related to our directors' common stock units, as well as the recognition of a $1.5 million gain during the second quarter of 2015 related to the release of restricted cash balances pertaining to the settlement of a working capital escrow account established in connection with the 2014 sale of our specialty business and mills. These decreases were partially offset by $2.0 million of non-routine legal expenses and settlement costs, including those related to a dispute involving one of our closed facilities, as well as $1.1 million in reorganization related expenses, incurred in the third quarter of 2015. Selling, general and administrative expenses also declined due to reduced headcount and administrative costs related to our Long Island facility closure and the sale of the specialty business and mills.
Impairment of assets—During the nine months ended September 30, 2014, as a result of the permanent closure of our Long Island facility, we recorded non-cash impairment losses during 2014 for intangible and long-lived assets in the amounts of $1.3 million and $3.8 million, respectively.
Interest expense—Interest expense for the nine months ended September 30, 2015 decreased by $7.6 million compared to the same period of 2014. The decrease was largely attributable to reduced interest rates on our debt as a result of the third quarter 2014 redemption of the 2010 Notes and the issuance of the lower interest bearing 2014 Notes.
Debt retirement costs—Debt retirement costs include a one-time $24.4 million charge in connection with the redemption of the 2010 Notes on August 28, 2014. These costs were comprised of cash charges of $19.8 million, which consisted of a "make-whole" premium of $17.6 million plus unpaid interest of $2.2 million, and a non-cash charge of $4.6 million related to the write-off of deferred issuance costs.

30



Income tax provision—We recorded an income tax provision of $19.5 million in the nine months ended September 30, 2015, compared to $17.2 million in the same period of 2014. The rate determined under GAAP for the nine months ended September 30, 2015 was approximately 31% compared to a rate of approximately 41% for the same period of 2014. The net decrease to our effective tax rate in the nine months ended September 30, 2015, was primarily the result of federal and state adjustments to valuation allowances. Based upon further review and analysis, certain state net operating losses were determined to no longer require a valuation allowance, which reduced tax expense during the quarter by approximately $2 million or a 2.8% rate reduction.
During the nine months ended September 30, 2015 and September 30, 2014, there were a number of items that were included in the calculation of our income tax provision that we do not believe were indicative of our core operating performance. Excluding these items, the adjusted tax rate for the nine months ended September 30, 2015 would have been approximately 31% compared to an adjusted rate of approximately 37% for the nine months ended September 30, 2014. The following table details these items:
 
Nine Months Ended
 
September 30,
(In thousands)
2015
 
2014
Income tax provision
$
(19,500
)
 
$
(17,235
)
Special items, tax impact:
 
 
 
Directors' equity-based compensation benefit (expense)
1,211

 
(937
)
Legal expenses and settlement costs
(626
)
 

Reorganization related expenses
(376
)
 

Costs associated with Long Island facility closure
(633
)
 
(5,386
)
Debt retirement costs

 
(8,643
)
Adjustments associated with optimization and sale of specialty mills
459

 
(377
)
Costs associated with labor agreement
(533
)
 

Costs associated with Thomaston facility closure

 
(417
)
Discrete tax items related to New York

 
1,388

Adjusted income tax provision
$
(19,998
)
 
$
(31,607
)

31



Discussion of Business Segments
Consumer Products
 
Nine Months Ended
  
September 30,
(Dollars in thousands - except per ton amounts)
2015
 
2014
Net sales
$
721,606

 
$
891,742

Operating income
44,948

 
24,717

Percent of net sales
6.2
%
 
2.8
%
 
 
 
 
Shipments (short tons)
 
 
 
Non-retail
67,101

 
176,178

Retail
219,434

 
221,487

Total tissue tons
286,535

 
397,665

Converted products cases (in thousands)
39,525

 
41,898

 
 
 
 
Sales price (per short ton)
 
 
 
Non-retail
$
1,476

 
$
1,503

Retail
2,831

 
2,823

Total tissue
$
2,514

 
$
2,238

Net sales for our Consumer Products segment decreased $170.1 million for the nine months ended September 30, 2015, compared to the same period of 2014 due to a decline in non-retail shipments resulting from the sale of our specialty business and mills. The segment's net sales were also lower due to a decrease in converted products cases sold, a 1.8% decline in non-retail selling prices and lower retail sales.
Segment operating income for the nine months ended September 30, 2015 increased by $20.2 million compared to the same period of 2014, primarily due to $2.0 million of costs related to the closure of our Long Island facility incurred during the first nine months of 2015, compared to $16.2 million of costs related to the closure of our Thomaston and Long Island facilities incurred during the same period of 2014. In addition, the 2014 operating costs also included incremental costs associated with the extreme cold weather conditions in the Midwest and Northeast. Those favorable comparisons were partially offset by $0.8 million of costs in 2015 associated with a new collective bargaining agreement at our Idaho facility, slightly higher purchased pulp and the absence of income generated by our specialty business and mills.
Pulp and Paperboard
 
Nine Months Ended
  
September 30,
(Dollars in thousands - except per ton amounts)
2015
 
2014
Net sales
$
599,200

 
$
603,079

Operating income
81,394

 
116,013

Percent of net sales
13.6
%
 
19.2
%
 
 
 
 
Paperboard shipments (short tons)
595,153

 
598,198

Paperboard sales price (per short ton)
$
1,002

 
$
1,007

Net sales for the Pulp and Paperboard segment decreased by $3.9 million during the nine months ended September 30, 2015, compared to the same period of 2014. The decrease was primarily due to slight decreases in paperboard shipments and net selling prices.
Operating income for the segment decreased $34.6 million during the nine months ended September 30, 2015, compared to the same period of 2014, primarily due to approximately $22 million of planned major maintenance costs incurred at our Idaho and Arkansas facilities during the first half of 2015 and $0.9 million of costs associated with the new collective bargaining agreement at our Idaho facility. These unfavorable comparisons were partially offset by lower chemical consumption related to the resolution of operational issues at our Arkansas facility experienced during the nine month period ended September 30, 2014, as well as lower packaging costs due to favorable pricing and lower energy costs due to favorable natural gas pricing throughout the segment.

32



EARNINGS BEFORE INTEREST, TAX, DEPRECIATION AND AMORTIZATION (EBITDA) AND ADJUSTED EBITDA
We use earnings before interest, taxes, depreciation and amortization, or EBITDA, and EBITDA adjusted for certain items, or Adjusted EBITDA, as supplemental performance measures that are not required by, or presented in accordance with GAAP. EBITDA and Adjusted EBITDA should not be considered as alternatives to net earnings, operating income or any other performance measure derived in accordance with GAAP, or as alternatives to cash flows from operating activities or a measure of our liquidity or profitability. In addition, our calculation of EBITDA and Adjusted EBITDA may or may not be comparable to similarly titled measures used by other companies.
We present EBITDA, Adjusted EBITDA and Adjusted income tax provisions because we believe they assist investors and analysts in comparing our performance across reporting periods on a consistent basis by excluding items that we do not believe are indicative of our core operating performance. In addition, we use EBITDA and Adjusted EBITDA: (i) as factors in evaluating management’s performance when determining incentive compensation, (ii) to evaluate the effectiveness of our business strategies and (iii) because our credit agreement and the indentures governing the 2013 Notes and 2014 Notes use metrics similar to EBITDA to measure our compliance with certain covenants.
The following table provides our EBITDA and Adjusted EBITDA for the periods presented, as well as a reconciliation to net earnings.
 
 
Three Months Ended
 
Nine Months Ended
 
September 30,
 
September 30,
(In thousands)
2015
 
2014
 
2015
 
2014
Net earnings
$
23,064

 
$
6,253

 
$
44,418

 
$
24,932

Interest expense, net1
7,882

 
33,990

 
23,438

 
55,412

Income tax provision
9,100

 
3,735

 
19,500

 
17,235

Depreciation and amortization expense
21,204

 
22,293

 
62,844

 
66,539

EBITDA
$
61,250

 
$
66,271

 
$
150,200

 
$
164,118

Directors' equity-based compensation (benefit) expense
(1,914
)
 
(185
)
 
(3,841
)
 
2,596

Legal expenses and settlement costs
1,972

 

 
1,972

 

Reorganization related expenses
1,185

 

 
1,185

 

Costs associated with Long Island facility closure
728

 
4,767

 
2,017

 
15,042

Adjustments associated with optimization and
sale of the specialty mills

 
1,066

 
(1,462
)
 
1,066

Costs associated with labor agreement

 

 
1,730

 

Costs associated with Thomaston facility closure

 
42

 

 
1,166

Adjusted EBITDA
$
63,221

 
$
71,961

 
$
151,801

 
$
183,988

1
Interest expense, net for the three and nine months ended September 30, 2014 includes debt retirement costs of $24.4 million. 
LIQUIDITY AND CAPITAL RESOURCES
The following table presents information regarding our cash flows for the nine months ended September 30, 2015 and 2014:
(In thousands)
2015
 
2014
Net cash flows from operating activities
$
107,555

 
$
101,931

Net cash flows from investing activities
(37,874
)
 
16,704

Net cash flows from financing activities
(83,595
)
 
(128,732
)
Cash Flows Summary
Net cash flows from operating activities for the nine months ended September 30, 2015 increased by $5.6 million compared to the same period in 2014. The increase in operating cash flows was largely due to a $28.7 million increase in cash flows generated from working capital and a $12.8 million decrease in contributions to our qualified pension plans during the first nine months of 2015 compared to the same period in 2014. The cash flows generated from working capital were primarily the result of a decrease in inventories and higher accounts payable and accrued liabilities, partially offset by higher accounts receivable. These increases in operating cash flows were partially offset by lower earnings, after adjusting for noncash related items, which decreased $26.9 million compared to the first nine months of 2014, and a $6.6 million decrease in cash generated from taxes receivable. The decrease in earnings after noncash items was primarily due to a $12.4 million deferred tax benefit during the first nine months of 2015 compared to a $12.9 million deferred tax provision during the same period of 2014.

33



Net cash flows from investing activities decreased by $54.6 million as a result of a $24.4 million increase in capital spending for plant and equipment, compared to the first nine months of 2014. The increase in capital spending is due in part to our focus on strategic capital projects, including our recently announced continuous pulp digester project at our Lewiston, Idaho facility. In addition, net investing cash flows were also impacted by the conversion of $40.0 million of short-term investments into cash during the first nine months of 2015, compared to the conversion of $70.0 million of short-term investments into cash during the same period of 2014.
Net cash flows used for financing activities were $83.6 million for the first nine months of 2015, and were largely driven by $84.3 million in repurchases of our outstanding common stock pursuant to our most recent $100 million stock repurchase program. Net cash flows used for financing activities were $128.7 million for the nine months ended September 30, 2014, and were largely driven by the completion of a previous $100.0 million stock repurchase program, as well as a $28.0 million net decrease in long-term debt and short-term borrowings associated largely with the issuance of the 2014 Notes and retirement of the 2010 Notes. 
Capital Resources
Due to the competitive and cyclical nature of the markets in which we operate, there is uncertainty regarding the amount of cash flows we will generate during the next twelve months. However, we believe that our cash flows from operations, our cash on hand and short-term investments, as well as borrowing capacity under our senior secured revolving credit facility will be adequate to fund our debt service requirements and provide cash required to support our ongoing operations, capital expenditures and working capital needs for the next twelve months.
We may choose to refinance all or a portion of our indebtedness on or before maturity. We cannot be certain that we will be able to refinance any of our indebtedness on commercially reasonable terms or at all.
Debt Arrangements
Our annual debt service obligation, consisting of cash payments for interest on the 2013 Notes and the 2014 Notes, is estimated to be $28.6 million for 2015.
The terms of the 2013 Notes limit our ability and the ability of any restricted subsidiaries to borrow money; pay dividends; redeem or repurchase capital stock; make investments; sell assets; create restrictions on the payment of dividends or other amounts to us from any restricted subsidiaries; enter into transactions with affiliates; enter into sale and lease back transactions; create liens; and consolidate, merge or sell all or substantially all of our assets. The terms of the 2014 Notes limit our ability and the ability of any restricted subsidiaries to incur certain liens, engage in sale and leaseback transactions and consolidate, merge with, or convey, transfer or lease substantially all of our or their assets to another person.
Credit Arrangements
As of September 30, 2015, there were no borrowings outstanding under the credit facility, but $6.2 million of the credit facility was being used to support outstanding standby letters of credit. Loans under the credit facility bear interest (i) for LIBOR loans, LIBOR plus between 1.25% and 1.75% and (ii) for base rate loans, a per annum rate equal to the greater of the following rates plus between 0.25% and 0.75%: (a) the rate of interest announced by Bank of America from time to time as its prime rate for such day; (b) the weighted average of interest rates on overnight federal funds transactions with members of the Federal Reserve System arranged by federal funds brokers for such day, plus 0.50%; or (c) LIBOR for a 30-day interest period as determined on such day, plus 1.00%. The percentage margin on all loans is based on our fixed charge coverage ratio for the most recent four quarters. As of September 30, 2015, we would have been permitted to draw an additional $118.8 million under the credit facility at LIBOR plus 1.25%, or base rate plus 0.25%.
CONTRACTUAL OBLIGATIONS
As of September 30, 2015, there were no significant changes to the contractual obligations table disclosed in our Annual Report on Form 10-K for the year ended December 31, 2014.
OFF-BALANCE SHEET ARRANGEMENTS
We currently are not a party to off-balance sheet arrangements that would require disclosure under this section.

34



CRITICAL ACCOUNTING POLICIES AND ESTIMATES
The preparation of financial statements in accordance with GAAP requires our management to select and apply accounting policies that best provide the framework to report our results of operations and financial position. The selection and application of those policies requires management to make difficult, subjective and complex judgments concerning reported amounts of revenue and expenses during the reporting period and the reported amounts of assets and liabilities at the date of the financial statements. As a result, it is possible that materially different amounts would be reported under different conditions or using different assumptions.
As of September 30, 2015, there have been no significant changes with regard to the critical accounting policies disclosed in our Annual Report on Form 10-K for the year ended December 31, 2014.
See Note 2 "Recently Adopted and New Accounting Standards" to the Consolidated Financial Statements included in Item 1 of this Quarterly Report on Form 10-Q for additional information regarding recently adopted and new accounting pronouncements.

ITEM 3.
 
Quantitative and Qualitative Disclosures About Market Risk
Interest Rate Risk
Our exposure to market risks on financial instruments includes interest rate risk on our secured revolving credit facility. As of September 30, 2015, there were no borrowings outstanding under the credit facility. The interest rates applied to borrowings under the credit facility are adjusted often and therefore react quickly to any movement in the general trend of market interest rates. For example, a one percentage point increase or decrease in interest rates, based on assumed outstanding credit facility borrowings of $10.0 million, would have an approximate $0.1 million annual effect on interest expense. We currently do not attempt to mitigate the effects of short-term interest rate fluctuations on our credit facility borrowings through the use of derivative financial instruments.
Commodity Risk
We are exposed to market risk for changes in natural gas commodity pricing, which we partially mitigate through the use of firm price contracts for a portion of our natural gas requirements for our manufacturing facilities. As of September 30, 2015, these contracts covered approximately 51% of our expected average monthly natural gas requirements for the remainder of 2015, plus lesser amounts for 2016.
Foreign Currency Risk
We have minimal foreign currency exchange risk. Virtually all of our international sales are denominated in U.S. dollars.

ITEM 4.
 
Controls and Procedures
We maintain “disclosure controls and procedures,” as such term is defined in Rule 13a-15(e) under the Securities and Exchange Act of 1934, or the Exchange Act, that are designed to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in SEC rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer, or CEO, and Chief Financial Officer, or CFO, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating our disclosure controls and procedures, management recognized that disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Additionally, in designing disclosure controls and procedures, our management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible disclosure controls and procedures. The design of disclosure controls and procedures is also based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.
Subject to the limitations noted above, our management, with the participation of our CEO and CFO, has evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the third quarter of 2015. Based on that evaluation, the CEO and CFO have concluded that, as of September 30, 2015, our disclosure controls and procedures were effective to meet the objective for which they were designed and operated at the reasonable assurance level.
Changes in Internal Controls
During the quarter ended September 30, 2015, we completed the conversion of our Consumer Products segment's order-to-invoicing system over to our enterprise resource planning system. While this conversion resulted in certain changes to our processes and procedures affecting our internal control over financial reporting, there have not been any changes in our internal control over financial reporting during our most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

35



Part II
ITEM 1.
 
Legal Proceedings
On August 13, 2012, we were notified that the U.S. Environmental Protection Agency, or EPA, submitted a civil referral to the U.S. Department of Justice, or DOJ, alleging violations of the Clean Air Act stemming from an EPA investigation that included an inspection of our Lewiston, Idaho pulp facility in July 2009 and a subsequent information request dated February 24, 2011. We reached an agreement with the DOJ and EPA in connection with this matter and paid a fine in the amount of $0.3 million in the third quarter of 2015.
In addition to the matters discussed above, we may from time to time be involved in claims, proceedings and litigation arising from our business and property ownership. We believe, based on currently available information, that the results of such proceedings, in the aggregate, will not have a material adverse effect on our financial condition.

ITEM 1A.
 
Risk Factors
There are no material changes from the risk factors previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2014. See Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2014, entitled “Risk Factors.”
ITEM 2.
 
Unregistered Sales of Equity Securities and Uses of Proceeds
Issuer Purchases of Equity Securities
On December 15, 2014, we announced that our Board of Directors had approved a new stock repurchase program authorizing the repurchase of up to $100 million of our common stock. The repurchase program authorized purchases of our common stock from time to time through open market purchases, negotiated transactions or other means, including accelerated stock repurchases and 10b5-1 trading plans in accordance with applicable securities laws and other restrictions. In total, we repurchased 1,750,808 shares of our outstanding common stock as of September 30, 2015, pursuant to this repurchase program, of which 1,151,313 shares were repurchased during the third quarter of 2015 at an average price of $49.23 per share. As of September 30, 2015, we had up to $6.2 million of authorization remaining pursuant to this stock repurchase program. Subsequent to the close of our third quarter ended September 30, 2015, we repurchased an additional 131,113 shares of our outstanding common stock at an average price of $46.97 per share, which completed the remainder of this repurchase program.
The following table provides information about share repurchases that we made during the three months ended September 30, 2015 (in thousands, except share and per share amounts):
Period
Total
Number of
Shares
Purchased
 
Average
Price Paid per
Share
 
Total
Number of
Shares
Purchased as
Part of Publicly
Announced
Program
 
Approximate
Dollar Value of
Shares that May
Yet Be  Purchased
Under the
Program
July 1, 2015 to July 31, 2015

 
$

 

 
$
62,852

August 1, 2015 to August 31, 2015
171,836

 
$
54.77

 
171,836

 
$
53,440

September 1, 2015 to September 30, 2015
979,477

 
$
48.26

 
979,477

 
$
6,169

Total
1,151,313

 
$
49.23

 
1,151,313

 
 
ITEM 6.
 
Exhibits
The exhibit index is located on page 38 of this Form 10-Q.

36



SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
 
 
 
 
 
 
 
CLEARWATER PAPER CORPORATION
 
 
 
(Registrant)
 
 
 
 
 
 
 
 
Date: November 3, 2015
 
By
/s/ JOHN D. HERTZ
 
 
 
 
John D. Hertz
 
 
 
 
Senior Vice President, Finance and
 
 
 
 
Chief Financial Officer
 
 
 
 
(Duly Authorized Officer; Principal
 
 
 
 
Financial Officer)
 
 
 
 
 
 
 
 
 
 
Date: November 3, 2015
 
By
/s/ ROBERT N. DAMMARELL
 
 
 
 
Robert N. Dammarell
 
 
 
 
Vice President, Corporate Controller
 
 
 
 
(Duly Authorized Officer; Principal
 
 
 
 
Accounting Officer)
 
 
 
 
 
 
 
 
 
 

37



CLEARWATER PAPER CORPORATION
EXHIBIT INDEX
 
EXHIBIT
NUMBER
 
DESCRIPTION
10.1
 
Eleventh Amendment to Loan and Security Agreement, dated as of September 28, 2015, by and among the financial institutions signatory thereto, Bank of America, N.A. and the Company.
 
 
 
(31)
 
Rule 13a-14(a)/15d-14(a) Certifications.
 
 
(32)*
 
Furnished statements of the Chief Executive Officer and Chief Financial Officer under 18 U.S.C Section 1350.
 
 
101.INS
 
XBRL Instance Document.
 
 
101.SCH
 
XBRL Taxonomy Extension Schema.
 
 
101.CAL
 
XBRL Taxonomy Extension Calculation Linkbase.
 
 
101.DEF
 
XBRL Taxonomy Extension Definition Linkbase.
 
 
101.LAB
 
XBRL Taxonomy Extension Label Linkbase.
 
 
101.PRE
 
XBRL Taxonomy Extension Presentation Linkbase.
* 
In accordance with Item 601(b)(32)(ii) of Regulation S-K and SEC Release No. 34-47986, the certifications furnished in Exhibit 32 hereto are deemed to accompany this Form 10-Q and will not be deemed “filed” for purposes of Section 18 of the Exchange Act. Such certifications will not be deemed to be incorporated by reference into any filing under the Securities Act or the Exchange Act.

38